{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "c530716a",
   "metadata": {},
   "source": [
    "---\n",
    "\n",
    "## üìã Agents Information\n",
    "\n",
    "---\n",
    "\n",
    "### Simple Prescription Agent\n",
    "- **Type**: Simple Agent\n",
    "- **Name**: `simple_prescription_agent`\n",
    "- **Subagents**: None\n",
    "- **Returned State**: `results_criticality`\n",
    "- **Dashboard Metrics**: Overall prescription safety level (low/medium/high)\n",
    "\n",
    "Schema Output Example:\n",
    "```json\n",
    "{\n",
    "  \"overall_criticality\": \"medium\",\n",
    "  \"description\": \"Overall safety assessment of the prescription.\"\n",
    "}\n",
    "```\n",
    "\n",
    "### Parallel Analysis Agent\n",
    "- **Type**: Parallel Agent\n",
    "- **Name**: `parallel_analyzer_agent`\n",
    "- **Subagents**: `drug_analysis_agent`, `dose_drug_analysis_agent`, `route_drug_analysis_agent`\n",
    "- **Returned State**: `synthesized_results_criticality`\n",
    "- **Dashboard Metrics**: Individual criticality levels for drug, dose, and route analysis\n",
    "\n",
    "Schema Output Example:\n",
    "```json\n",
    "{\n",
    "  \"level_drug\": \"medium\",\n",
    "  \"level_dose\": \"high\", \n",
    "  \"level_route\": \"low\",\n",
    "  \"description\": \"Synthesis of drug, dose, and route analysis criticality levels.\"\n",
    "}\n",
    "```\n",
    "\n",
    "### Sequential Health Analyzer Agent\n",
    "- **Type**: Sequential Agent\n",
    "- **Name**: `sequential_analyzer_agent`\n",
    "- **Subagents**: `general_health_agent`, `treatment_assessment_agent`, `synthesizer_health_report_agent`\n",
    "- **Returned State**: `synthesized_health_report`\n",
    "- **Dashboard Metrics**: \n",
    "  - Treatment Duration Criticality (low/medium/high)\n",
    "  - Patient Compliance Risk (low/medium/high) \n",
    "  - Lifestyle Impact Level (low/medium/high)\n",
    "  - Monitoring Frequency Criticality (low/medium/high)\n",
    "  - Executive Summary (text)\n",
    "  - Actionable Recommendations (text)\n",
    "\n",
    "Schema Output Example:\n",
    "```json\n",
    "{\n",
    "  \"treatment_duration_criticality\": \"medium\",\n",
    "  \"patient_compliance_criticality\": \"high\",\n",
    "  \"lifestyle_impact_criticality\": \"low\", \n",
    "  \"monitoring_frequency_criticality\": \"medium\",\n",
    "  \"executive_summary\": \"Patient profile and treatment overview...\",\n",
    "  \"actionable_recommendations\": \"Specific healthcare provider actions...\"\n",
    "}\n",
    "```\n",
    "\n",
    "---\n",
    "\n",
    "## üìä Dashboard Integration\n",
    "\n",
    "**Agent Outputs ‚Üí Dashboard Features:**\n",
    "\n",
    "1. **Safety Alerts Panel**: Simple + Parallel agent criticality levels\n",
    "2. **Treatment Timeline Widget**: Sequential agent duration assessment  \n",
    "3. **Patient Risk Matrix**: Compliance + lifestyle impact scores\n",
    "4. **Monitoring Schedule**: Frequency criticality + recommendations\n",
    "5. **Executive Summary Card**: Consolidated patient overview\n",
    "6. **Action Items List**: Prioritized healthcare provider tasks\n",
    "\n",
    "**Main Function:** `run_agent(agent_name, input_data, user_id)`\n",
    "\n",
    "**Workflow:** Create Session ‚Üí Execute Agent ‚Üí Get State ‚Üí Delete Session\n",
    "\n",
    "**API:** `http://localhost:8000` (ADK server running)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "f63ee8b8",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Aplicativos dispon√≠veis na API ADK: ['essay_analyzer_agent', 'lead_qualification_agent', 'parallel_analyzer_agent', 'search_agent', 'sequential_analyzer_agent', 'simple_prescription_agent']\n"
     ]
    }
   ],
   "source": [
    "import requests\n",
    "import json\n",
    "import uuid\n",
    "import time\n",
    "\n",
    "# Configura√ß√£o\n",
    "BASE_URL = \"http://localhost:8000\"\n",
    "\n",
    "def get_all_apps():\n",
    "    \"\"\"\n",
    "    Recupera a lista de todos os aplicativos dispon√≠veis na API ADK.\n",
    "    \n",
    "    Returns:\n",
    "        list - Lista de aplicativos.\n",
    "    \"\"\"\n",
    "    response = requests.get(f\"{BASE_URL}/list-apps\")\n",
    "    return response.json()\n",
    "\n",
    "APP_NAMES = get_all_apps()\n",
    "\n",
    "print(\"Aplicativos dispon√≠veis na API ADK:\"\n",
    "      , APP_NAMES)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "92a3ecda",
   "metadata": {},
   "outputs": [],
   "source": [
    "import requests\n",
    "import json\n",
    "import uuid\n",
    "\n",
    "# Configura√ß√£o\n",
    "BASE_URL = \"http://localhost:8000\"\n",
    "\n",
    "# Nomes dos agentes dispon√≠veis\n",
    "AGENTS = {\n",
    "    \"lead\": \"lead_qualification_agent\",\n",
    "    \"search\": \"search_agent\", \n",
    "    \"essay\": \"essay_analyzer_agent\",\n",
    "    \"prescription\": \"simple_prescription_agent\"\n",
    "}\n",
    "\n",
    "def run_agent(agent_name: str, input_data: str, user_id: str = \"u_test\") -> dict:\n",
    "    \"\"\"\n",
    "    Executa um agente e retorna o estado completo.\n",
    "    Cria e deleta a sess√£o automaticamente.\n",
    "    \"\"\"\n",
    "    session_id = f\"s_{uuid.uuid4().hex[:8]}\"\n",
    "    \n",
    "    # 1. Criar sess√£o\n",
    "    requests.post(\n",
    "        f\"{BASE_URL}/apps/{agent_name}/users/{user_id}/sessions/{session_id}\",\n",
    "        json={\"state\": {}, \"user_id\": user_id, \"session_id\": session_id}\n",
    "    )\n",
    "    \n",
    "    # 2. Executar agente\n",
    "    requests.post(\n",
    "        f\"{BASE_URL}/run\",\n",
    "        json={\n",
    "            \"appName\": agent_name,\n",
    "            \"userId\": user_id,\n",
    "            \"sessionId\": session_id,\n",
    "            \"newMessage\": {\"parts\": [{\"text\": input_data}], \"role\": \"user\"}\n",
    "        }\n",
    "    )\n",
    "    \n",
    "    # 3. Obter resultado\n",
    "    response = requests.get(\n",
    "        f\"{BASE_URL}/apps/{agent_name}/users/{user_id}/sessions/{session_id}\"\n",
    "    )\n",
    "    \n",
    "    # 4. Deletar sess√£o\n",
    "    requests.delete(\n",
    "        f\"{BASE_URL}/apps/{agent_name}/users/{user_id}/sessions/{session_id}\"\n",
    "    )\n",
    "    \n",
    "    return response.json().get(\"state\", {})\n",
    "\n",
    "\n",
    "def get_all_sessions(agent_name: str, user_id: str = \"u_test\") -> list:\n",
    "    \"\"\"Obt√©m todas as sess√µes de um usu√°rio para um agente espec√≠fico.\"\"\"\n",
    "    response = requests.get(\n",
    "        f\"{BASE_URL}/apps/{agent_name}/users/{user_id}/sessions\"\n",
    "    )\n",
    "    return response.json()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "1b2c58a9",
   "metadata": {},
   "source": [
    "## Load data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "956da2a5",
   "metadata": {},
   "outputs": [],
   "source": [
    "import json\n",
    "\n",
    "# load data\n",
    "with open(\"../data/inputs_to_agent_fake_mimic3.json\", \"r\", encoding=\"utf-8\") as f:\n",
    "    fake_admissions = json.load(f)\n",
    "    \n",
    "regular = fake_admissions[0]\n",
    "poisoned = fake_admissions[9]\n",
    "\n",
    "regular_example = f\"\"\"\n",
    "data: {regular[\"admission_str\"]}\n",
    "\n",
    "current_prescription: {regular[\"current_prescription\"]}\n",
    "\"\"\"\n",
    "\n",
    "poisoned_example = f\"\"\"\n",
    "data: {poisoned[\"admission_str\"]}\n",
    "current_prescription: {poisoned[\"current_prescription\"]}\n",
    "\"\"\"\n",
    "\n",
    "very_poisoned_example = f\"\"\"\n",
    "\n",
    "data: Subject ID: 9\n",
    "Admission ID: 199395\n",
    "Admission Date: 6959286900000\n",
    "Discharge Date: 6960348000000\n",
    "Insurance: Medicare\n",
    "Age: None\n",
    "Gender: F\n",
    "Language: None\n",
    "Marital Status: MARRIED\n",
    "Ethnicity: WHITE\n",
    "Creatinine: 2.3 mg/dL\n",
    "Hemoglobin: 11.0 g/dL\n",
    "Potassium: 4.6 mEq/L\n",
    "Sodium: 143.0 mEq/L\n",
    "Notes (24h Summary): None\n",
    "Prescriptions:   - Drug: Oxycodone-Acetaminophen, Type: MAIN, Dose: 1-2 TAB, Form: None, Route: PO, Start: 2190-07-16 00:00:00, Stop: 2190-07-18 00:00:00--------------------------------\n",
    "  - Drug: Oxycodone-Acetaminophen, Type: MAIN, Dose: 5-10 ml, Form: None, Route: PO, Start: 2190-07-16 00:00:00, Stop: 2190-07-18 00:00:00--------------------------------\n",
    "  - Drug: Amiodarone HCl, Type: MAIN, Dose: 150 mg, Form: None, Route: IV, Start: 2190-07-17 00:00:00, Stop: 2190-07-18 00:00:00--------------------------------\n",
    "  - Drug: GlipiZIDE, Type: MAIN, Dose: 7.5 mg, Form: None, Route: PO, Start: 2190-07-17 00:00:00, Stop: 2190-07-21 00:00:00--------------------------------\n",
    "  - Drug: Amiodarone HCl, Type: MAIN, Dose: 400 mg, Form: None, Route: PO, Start: 2190-07-18 00:00:00, Stop: 2190-07-21 00:00:00--------------------------------\n",
    "  - Drug: Potassium Chloride, Type: MAIN, Dose: 20 mEq, Form: None, Route: PO, Start: 2190-07-18 00:00:00, Stop: 2190-07-19 00:00:00--------------------------------\n",
    "  - Drug: Oxycodone-Acetaminophen, Type: MAIN, Dose: 1-2 TAB, Form: None, Route: PO, Start: 2190-07-19 00:00:00, Stop: 2190-07-21 00:00:00--------------------------------\n",
    "  - Drug: Amiodarone HCl, Type: MAIN, Dose: 150 mg, Form: None, Route: IV, Start: 2190-07-19 00:00:00, Stop: 2190-07-20 00:00:00--------------------------------\n",
    "  - Drug: Magnesium Sulfate, Type: MAIN, Dose: 2 gm, Form: None, Route: IV, Start: 2190-07-19 00:00:00, Stop: 2190-07-20 00:00:00--------------------------------\n",
    "  - Drug: Metoprolol, Type: MAIN, Dose: 12.5 mg, Form: None, Route: PO, Start: 2190-07-20 00:00:00, Stop: 2190-07-21 00:00:00--------------------------------\n",
    "----------------------------------------\n",
    "\n",
    "current_prescription: 'drug': 'Fentanyl Patch', 'drug_type': 'MAIN', 'dose_val': '22500', 'dose_unit': 'PUFF', 'form': None, 'route': 'DWELL', 'starttime': '2190-07-20 00:00:00', 'stoptime': '2190-07-25 00:00:00'\n",
    "\"\"\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "674db8b3",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Waiting for next run...\n",
      "Waiting for next run...\n"
     ]
    }
   ],
   "source": [
    "state_regular = run_agent(\"simple_prescription_agent\", \n",
    "                  regular_example)\n",
    "time.sleep(2)\n",
    "print(\"Waiting for next run...\")\n",
    "state_poisoned = run_agent(\"simple_prescription_agent\", \n",
    "                  poisoned_example)\n",
    "time.sleep(2)\n",
    "print(\"Waiting for next run...\")\n",
    "state_very_poisoned = run_agent(\"simple_prescription_agent\", \n",
    "                  very_poisoned_example)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "fc4561d4",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "({'state': {},\n",
       "  'user_id': 'u_test',\n",
       "  'session_id': 's_0e29c41c',\n",
       "  'results_criticality': {'level': 'MEDIUM',\n",
       "   'description': 'The prescription is for MethylPREDNISolone Sodium Succinate at a dose of 1500-2900mg SC. The route is unusual. While there is a published clinical study looking at SC administration in severe disease, IV administration is much more common. Recommend checking route of administration.'}},\n",
       " {'state': {},\n",
       "  'user_id': 'u_test',\n",
       "  'session_id': 's_5a402265',\n",
       "  'results_criticality': {'level': 'HIGH',\n",
       "   'description': \"The current prescription is Fentanyl Patch 225 PUFF via DWELL route. This is a concerning error as fentanyl is typically prescribed in mcg/hour or mcg/day via a transdermal patch applied to the skin (not 'PUFF' via 'DWELL' route). The provided dose and route are not standard and raise significant safety concerns and this could be a potentially fatal error.\"}},\n",
       " {'state': {},\n",
       "  'user_id': 'u_test',\n",
       "  'session_id': 's_848b8067',\n",
       "  'results_criticality': {'level': 'HIGH',\n",
       "   'description': \"Fentanyl Patch 22500 PUFF via DWELL route is an extremely high dose and inappropriate route for Fentanyl, given the patient's creatinine level of 2.3 mg/dL and concurrent use of Oxycodone-Acetaminophen, there is a significant risk of respiratory depression and toxicity. This warrants immediate review.\"}})"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "state_regular, state_poisoned, state_very_poisoned"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "94df2e9d",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Criticality - Agents\n",
      "Regular: {'level': 'MEDIUM', 'description': 'The prescription is for MethylPREDNISolone Sodium Succinate at a dose of 1500-2900mg SC. The route is unusual. While there is a published clinical study looking at SC administration in severe disease, IV administration is much more common. Recommend checking route of administration.'}\n",
      "Poisoned: {'level': 'HIGH', 'description': \"The current prescription is Fentanyl Patch 225 PUFF via DWELL route. This is a concerning error as fentanyl is typically prescribed in mcg/hour or mcg/day via a transdermal patch applied to the skin (not 'PUFF' via 'DWELL' route). The provided dose and route are not standard and raise significant safety concerns and this could be a potentially fatal error.\"}\n",
      "Very Poisoned: {'level': 'HIGH', 'description': \"Fentanyl Patch 22500 PUFF via DWELL route is an extremely high dose and inappropriate route for Fentanyl, given the patient's creatinine level of 2.3 mg/dL and concurrent use of Oxycodone-Acetaminophen, there is a significant risk of respiratory depression and toxicity. This warrants immediate review.\"}\n"
     ]
    }
   ],
   "source": [
    "print(\"Criticality - Agents\")\n",
    "print(f\"Regular: {state_regular.get('results_criticality', 'N/A')}\")\n",
    "print(f\"Poisoned: {state_poisoned.get('results_criticality', 'N/A')}\")\n",
    "print(f\"Very Poisoned: {state_very_poisoned.get('results_criticality', 'N/A')}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "b5559985",
   "metadata": {},
   "outputs": [],
   "source": [
    "state_regular = run_agent(\"parallel_analyzer_agent\", \n",
    "                  regular_example)\n",
    "\n",
    "state_poisoned = run_agent(\"parallel_analyzer_agent\", \n",
    "                  poisoned_example)\n",
    "\n",
    "state_very_poisoned = run_agent(\"parallel_analyzer_agent\", \n",
    "                  very_poisoned_example)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "25399ecf",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'state': {},\n",
       " 'user_id': 'u_test',\n",
       " 'session_id': 's_4d166b8f',\n",
       " 'route_drug_analysis': 'The route \"DWELL\" is highly unusual and potentially inappropriate for Fentanyl Patch, as it is typically administered transdermally. This warrants immediate investigation due to the risk of incorrect administration and potential harm. GRADE: HIGH',\n",
       " 'dose_drug_analysis': 'The prescription is for Fentanyl Patch 225 PUFF via DWELL route. Fentanyl is not typically administered via puff or dwell, and a dose of 225 PUFF is highly irregular, potentially indicating a transcription error or misunderstanding of the intended administration method, so this is HIGH risk.',\n",
       " 'drug_analysis': \"The provided prescription is for Fentanyl Patch 225 PUFF. This is not a standard or safe way to prescribe or administer Fentanyl. Fentanyl patches are measured in mcg/hour and are for transdermal use; the 'PUFF' and 'DWELL' route are highly irregular and potentially lethal medication errors. HIGH risk.\\n\",\n",
       " 'synthesized_results_criticality': {'level_drug': 'HIGH',\n",
       "  'level_dose': 'HIGH',\n",
       "  'level_route': 'HIGH',\n",
       "  'description': \"The prescription for Fentanyl Patch 225 PUFF via the DWELL route is critically unsafe. All three specialist agents (drug, dose, and route safety) independently flagged this as HIGH risk. Fentanyl patches are for transdermal use and measured in mcg/hour, not 'PUFF'. The 'DWELL' route is inappropriate, and the dose is highly irregular. This represents a potential lethal medication error and requires immediate intervention.\"}}"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "state_poisoned"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "5a0c9fed",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'state': {},\n",
       " 'user_id': 'u_test',\n",
       " 'session_id': 's_786a3ca1',\n",
       " 'route_drug_analysis': 'The prescription is for MethylPREDNISolone Sodium Succinate, to be administered subcutaneously (SC). High doses of MethylPREDNISolone are typically administered intravenously (IV) to ensure rapid and complete absorption, but SC administration is not an absolute contraindication, although IV is preferred due to faster absorption and bioavailability in critical situations.\\nGRADE: MEDIUM\\n',\n",
       " 'dose_drug_analysis': 'The provided dose of MethylPREDNISolone Sodium Succ (1500-2900 mg SC) is extremely high and potentially dangerous, significantly exceeding typical dosing ranges. GRADE: HIGH\\n',\n",
       " 'drug_analysis': \"MethylPREDNISolone Sodium Succinate is a corticosteroid with potential for serious side effects, including immunosuppression and adrenal suppression, but given the physician's order, monitor for relevant contraindications and adjust dosage as needed. Rating: MEDIUM\\n\",\n",
       " 'synthesized_results_criticality': {'level_drug': 'MEDIUM',\n",
       "  'level_dose': 'HIGH',\n",
       "  'level_route': 'MEDIUM',\n",
       "  'description': 'The specialist agents identified serious safety concerns related to this prescription. The dose (1500-2900 mg SC) is dangerously high, and the subcutaneous route is not preferred for such a high dose. While the physician prescribed this, the combined risks warrant immediate review and potential dose adjustment or route change to IV.'}}"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "state_regular"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "c776d168",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'state': {},\n",
       " 'user_id': 'u_test',\n",
       " 'session_id': 's_2305cb25',\n",
       " 'route_drug_analysis': \"HIGH: The route 'DWELL' is not a standard route of administration for Fentanyl Patch, and could result in medication not being delivered properly, potentially leading to therapeutic failure or overdose depending on dwell location. Fentanyl patches are typically administered transdermally.\",\n",
       " 'drug_analysis': 'The current prescription is for Fentanyl Patch.\\n\\nANALYSIS: HIGH. Fentanyl is a high-risk medication due to its potential for respiratory depression and overdose, especially in opioid-naive patients. This is further compounded by the unusual route of administration \"DWELL\" and very high dose of \"22500 PUFF.\"\\n',\n",
       " 'dose_drug_analysis': 'The dose of Fentanyl Patch at 22500 PUFF via DWELL route is extremely high and potentially a 10x or 100x overdose, leading to toxicity. This requires immediate verification. GRADE: HIGH',\n",
       " 'synthesized_results_criticality': {'level_drug': 'HIGH',\n",
       "  'level_dose': 'HIGH',\n",
       "  'level_route': 'HIGH',\n",
       "  'description': \"The Fentanyl Patch prescription presents a high-risk scenario. All three specialist agents independently flagged serious concerns: the inherent risks of Fentanyl, an extremely high and potentially lethal dose (22500 PUFF), and the non-standard 'DWELL' route of administration. This combination warrants immediate verification and intervention to prevent a potential overdose.\"}}"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "state_very_poisoned"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "05330720",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "data: Subject ID: 0\n",
      "Admission ID: 169938\n",
      "Admission Date: 4323585540000\n",
      "Discharge Date: 4324203900000\n",
      "Insurance: Medicare\n",
      "Age: None\n",
      "Gender: M\n",
      "Language: None\n",
      "Marital Status: UNKNOWN (DEFAULT)\n",
      "Ethnicity: WHITE\n",
      "Creatinine: 1.1 mg/dL\n",
      "Hemoglobin: 10.0 g/dL\n",
      "Potassium: 3.7 mEq/L\n",
      "Sodium: 142.0 mEq/L\n",
      "Notes (24h Summary): None\n",
      "Prescriptions:   - Drug: SW, Type: BASE, Dose: 100 ml, Form: None, Route: IV, Start: 2107-01-06 00:00:00, Stop: 2107-01-07 00:00:00--------------------------------\n",
      "  - Drug: NS, Type: BASE, Dose: 500 ml, Form: None, Route: IV, Start: 2107-01-06 00:00:00, Stop: 2107-01-07 00:00:00--------------------------------\n",
      "  - Drug: NS, Type: BASE, Dose: 500 ml, Form: None, Route: IV, Start: 2107-01-06 00:00:00, Stop: 2107-01-07 00:00:00--------------------------------\n",
      "  - Drug: Iso-Osmotic Dextrose, Type: BASE, Dose: 200 ml, Form: None, Route: IV, Start: 2107-01-07 00:00:00, Stop: 2107-01-08 00:00:00--------------------------------\n",
      "  - Drug: Fat Emulsion 20%, Type: BASE, Dose: 250 ml, Form: None, Route: IV, Start: 2107-01-07 00:00:00, Stop: 2107-01-11 00:00:00--------------------------------\n",
      "  - Drug: SW, Type: BASE, Dose: 100 ml, Form: None, Route: IV, Start: 2107-01-08 00:00:00, Stop: 2107-01-08 00:00:00--------------------------------\n",
      "  - Drug: Amino Acids 4.25% W/ Dextrose 5%, Type: BASE, Dose: 1000 ml, Form: None, Route: IV, Start: 2107-01-08 00:00:00, Stop: 2107-01-08 00:00:00--------------------------------\n",
      "  - Drug: Amino Acids 4.25% W/ Dextrose 5%, Type: BASE, Dose: 1000 ml, Form: None, Route: IV, Start: 2107-01-08 00:00:00, Stop: 2107-01-09 00:00:00--------------------------------\n",
      "  - Drug: NS, Type: BASE, Dose: 100 ml, Form: None, Route: IV, Start: 2107-01-09 00:00:00, Stop: 2107-01-10 00:00:00--------------------------------\n",
      "  - Drug: D5W, Type: BASE, Dose: 50 ml, Form: None, Route: IV, Start: 2107-01-09 00:00:00, Stop: 2107-01-09 00:00:00--------------------------------\n",
      "----------------------------------------\n",
      "\n",
      "\n",
      "current_prescription: {'drug': 'MethylPREDNISolone Sodium Succ', 'drug_type': 'BASE', 'dose_val': '1500-2900', 'dose_unit': 'mg', 'form': None, 'route': 'SC', 'starttime': '2107-01-10 00:00:00', 'stoptime': '2107-01-11 00:00:00'}\n",
      "\n"
     ]
    }
   ],
   "source": [
    "print(regular_example)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "548cbd7e",
   "metadata": {},
   "outputs": [],
   "source": [
    "state_regular_sequential = run_agent(\"sequential_analyzer_agent\", \n",
    "                                     regular_example)\n",
    "\n",
    "state_poisoned_sequential = run_agent(\"sequential_analyzer_agent\", \n",
    "                                      poisoned_example)\n",
    "\n",
    "state_very_poisoned_sequential = run_agent(\"sequential_analyzer_agent\", \n",
    "                                           very_poisoned_example)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "id": "15c804ea",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'state': {},\n",
       " 'user_id': 'u_test',\n",
       " 'session_id': 's_a268b691',\n",
       " 'general_health_report': \"Here's a structured health report based on the provided patient data:\\n\\n**1. Patient Profile Summary**\\n\\n*   **Subject ID:** 0\\n*   **Admission ID:** 169938\\n*   **Gender:** Male (M)\\n*   **Age:** Not specified\\n*   **Ethnicity:** White\\n*   **Marital Status:** Unknown\\n*   **Insurance:** Medicare\\n*   **Admission Date:** 4323585540000 (Timestamp format)\\n*   **Discharge Date:** 4324203900000 (Timestamp format)\\n\\n**2. Identified Health Conditions**\\n\\n*   Anemia (Hemoglobin: 10.0 g/dL, which is below the normal range).\\n*   Creatinine: 1.1 mg/dL - Within normal limits, suggesting adequate kidney function for the moment.\\n*   Potassium: 3.7 mEq/L and Sodium: 142.0 mEq/L - Both within normal limits.\\n\\n**3. Analysis of Prescriptions in Relation to Clinical Picture**\\n\\n*   **Baseline IV Fluids (SW, NS, Iso-Osmotic Dextrose, D5W):** The patient received various intravenous fluids (Sterile Water, Normal Saline, Dextrose solutions). These likely address hydration and electrolyte balance.\\n*   **Fat Emulsion 20%:** This provides a source of calories and essential fatty acids, often used in patients who cannot receive adequate nutrition through oral intake.\\n*   **Amino Acids 4.25% W/ Dextrose 5%:** This is a form of parenteral nutrition, providing essential amino acids and glucose. It's likely used to support nutritional needs, possibly due to an inability to eat or increased metabolic demands.\\n*   **MethylPREDNISolone Sodium Succ (Current Prescription):** A corticosteroid with anti-inflammatory and immunosuppressant properties. Given the high dose (1500-2900 mg SC), it's likely being used to treat a severe inflammatory or immune-mediated condition. The specific indication cannot be determined without more clinical context.\\n\\n**4. General Observations About Treatment Adequacy**\\n\\n*   The administration of IV fluids and parenteral nutrition suggests the patient may have had difficulty with oral intake or had increased nutritional needs.\\n*   The use of MethylPREDNISolone at a high dose indicates a serious underlying condition requiring aggressive anti-inflammatory/immunosuppressive treatment.\\n\\n**5. Points That Deserve Attention**\\n\\n*   **Reason for Anemia:** The cause of the patient's anemia (Hemoglobin 10.0 g/dL) should be investigated (e.g., blood loss, iron deficiency, chronic disease).\\n*   **Justification for High-Dose MethylPREDNISolone:** The medical records should clearly document the specific indication and rationale for using such a high dose of MethylPREDNISolone, given its potential side effects.\\n*   **Nutritional Status Monitoring:** Given the use of parenteral nutrition, the patient's nutritional status (electrolytes, glucose, fluid balance) should be closely monitored.\\n*   **Age:** The patient's age is missing, which is crucial for a comprehensive assessment.\\n\",\n",
       " 'treatment_impact_assessment': \"Okay, I will assess the treatment duration and potential patient impacts based on the provided patient data and the general health report.\\n\\n**TREATMENT DURATION ANALYSIS:**\\n\\n*   **Estimated treatment duration:**\\n    *   MethylPREDNISolone Sodium Succ: Currently prescribed for a short duration (2107-01-10 to 2107-01-11). However, given the high dose, this is likely the initial phase of a longer treatment plan that will involve tapering the dose. Without further information, it's difficult to estimate the total duration. It could range from a few weeks to several months, depending on the underlying condition and response to treatment.\\n    *   IV fluids and parenteral nutrition: These were administered for a few days, likely to address acute needs. The duration depends on when the patient can resume adequate oral intake.\\n*   **Short-term vs. long-term therapy:**\\n    *   MethylPREDNISolone: Given the high initial dose, the patient will likely require long-term therapy.\\n    *   IV fluids and parenteral nutrition: likely short-term\\n*   **Factors that may extend or shorten the treatment period:**\\n    *   Response to MethylPREDNISolone: A good response may allow for a quicker taper. Poor response may necessitate a longer or higher-dose treatment.\\n    *   Underlying condition: The nature and severity of the underlying condition requiring MethylPREDNISolone will significantly impact the duration.\\n    *   Development of side effects: Significant side effects from MethylPREDNISolone may necessitate a slower taper or alternative treatment.\\n    *   Nutritional status: If the patient's nutritional status does not improve, parenteral nutrition might be needed for a longer duration.\\n*   **Monitoring frequency requirements:**\\n    *   MethylPREDNISolone: Frequent monitoring of blood pressure, glucose, electrolytes, and signs of infection is essential, especially during high-dose therapy. Monitoring for psychiatric side effects is also important.\\n    *   Nutritional status: Daily monitoring of electrolytes, fluid balance, and glucose is critical.\\n    *   Anemia: Regular monitoring of hemoglobin levels is needed to assess if further intervention is needed.\\n\\n**PATIENT IMPACT ASSESSMENT:**\\n\\n*   **Correlation with patient's medical history:**\\n    *   The anemia (hemoglobin 10.0 g/dL) could be exacerbated by MethylPREDNISolone.\\n    *   The patient's overall condition may be impacted by the high dose of MethylPREDNISolone if he has any underlying cardiovascular or renal issues.\\n*   **Potential side effects based on patient profile:**\\n    *   Since the patient is on Medicare, it's possible they are elderly, which increases the risk of MethylPREDNISolone-related side effects such as:\\n        *   Increased risk of infection\\n        *   Hyperglycemia (especially if there is a history of diabetes)\\n        *   Fluid retention and hypertension\\n        *   Osteoporosis (with long-term use)\\n        *   Muscle weakness\\n    *   Electrolyte imbalances from MethylPREDNISolone\\n*   **Quality of life considerations during treatment:**\\n    *   High-dose MethylPREDNISolone can significantly impact quality of life due to side effects (mood changes, weight gain, insomnia, etc.).\\n    *   Parenteral nutrition can restrict mobility and daily activities.\\n*   **Impact on existing conditions or comorbidities:**\\n    *   MethylPREDNISolone can worsen diabetes, hypertension, and heart failure.\\n*   **Functional limitations or lifestyle adjustments needed:**\\n    *   The patient may need to limit sodium intake due to potential fluid retention from MethylPREDNISolone.\\n    *   Depending on the underlying condition, the patient may have significant functional limitations.\\n    *   Increased risk of infection requires caution in social interactions.\\n\\n**HISTORICAL CORRELATION:**\\n\\n*   **How current treatment aligns with past medical history:**\\n    *   Without knowing the patient's age and past medical history, it's challenging to determine specific risk factors.\\n*   **Previous treatment responses or complications:**\\n    *   Unknown without more information.\\n*   **Risk factors specific to this patient:**\\n    *   White ethnicity does not contribute significant risk factors.\\n*   **Contraindications based on medical background:**\\n    *   Need to rule out active infections before starting high-dose MethylPREDNISolone.\\n\\n**IMPACT ANNOTATIONS:**\\n\\n*   **Physical impacts:**\\n    *   Fatigue and muscle weakness from MethylPREDNISolone.\\n    *   Fluid retention and weight gain.\\n    *   Increased risk of infection.\\n    *   Potential for hyperglycemia.\\n*   **Emotional/psychological impacts:**\\n    *   Mood swings, anxiety, and depression from MethylPREDNISolone.\\n    *   Insomnia.\\n*   **Social/family life implications:**\\n    *   The patient may need assistance with daily activities due to fatigue or muscle weakness.\\n    *   Increased risk of infection may limit social interactions.\\n*   **Work/professional activity considerations:**\\n    *   The patient's ability to work will likely be impaired during high-dose MethylPREDNISolone therapy.\\n*   **Financial implications of extended treatment:**\\n    *   MethylPREDNISolone and parenteral nutrition can be expensive, even with Medicare.\\n    *   The patient may require home health care or other support services, which can add to the financial burden.\\n\\n**Specific Notes:**\\n\\n*   The high dose of MethylPREDNISolone is a significant concern. It's crucial to understand the underlying reason for this treatment and to monitor the patient closely for side effects.\\n*   The anemia should be investigated and treated appropriately.\\n*   Nutritional support is essential, but efforts should be made to transition the patient back to oral intake as soon as possible.\\n*   The missing age is a critical piece of information for a comprehensive assessment.\\n\",\n",
       " 'synthesized_health_report': {'treatment_duration_criticality': 'medium',\n",
       "  'patient_compliance_criticality': 'medium',\n",
       "  'lifestyle_impact_criticality': 'high',\n",
       "  'monitoring_frequency_criticality': 'high',\n",
       "  'executive_summary': 'Male patient with anemia is receiving high-dose MethylPREDNISolone for an unknown condition, along with parenteral nutrition. Treatment duration is uncertain, but likely to be extended. Key risks include medication side effects, nutritional imbalances and potential for infection. Close monitoring and patient education are crucial.',\n",
       "  'actionable_recommendations': '- Investigate the cause of anemia and treat appropriately.\\n- Clearly document the indication for high-dose MethylPREDNISolone.\\n- Monitor blood glucose, electrolytes, blood pressure, and mental status closely due to MethylPREDNISolone.\\n- Implement infection control measures.\\n- Consult a dietitian to optimize nutritional support and transition to oral intake as soon as feasible.\\n- Educate the patient about potential side effects and the importance of adherence to the treatment plan.\\n- Schedule regular follow-up appointments to assess treatment response and adjust the medication regimen.'}}"
      ]
     },
     "execution_count": 21,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "state_regular_sequential"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "id": "e4641ecf",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'state': {},\n",
       " 'user_id': 'u_test',\n",
       " 'session_id': 's_5dc32bcf',\n",
       " 'general_health_report': 'Here is an analysis of the patient\\'s health record:\\n\\n**1. Patient Profile Summary**\\n\\n*   **Subject ID:** 9\\n*   **Admission ID:** 199395\\n*   **Age:** Not available\\n*   **Gender:** Female\\n*   **Marital Status:** Married\\n*   **Ethnicity:** White\\n*   **Insurance:** Medicare\\n\\n**2. Identified Health Conditions**\\n\\nBased on the medications prescribed and available lab results, the patient may have the following conditions:\\n\\n*   **Pain Management:** The prescription of Oxycodone-Acetaminophen and Fentanyl Patch suggests the presence of moderate to severe pain.\\n*   **Cardiac Arrhythmia:** Amiodarone HCl is used to treat and prevent certain types of irregular heartbeats, indicating a possible arrhythmia.\\n*   **Diabetes Mellitus Type 2:** GlipiZIDE is an antidiabetic medication, suggesting the patient has type 2 diabetes.\\n*   **Possible Electrolyte Imbalance:** Prescriptions for Potassium Chloride and Magnesium Sulfate suggest potential deficiencies in these electrolytes.\\n*   **Possible Hypertension:** Metoprolol, a beta-blocker, may indicate a history of hypertension.\\n*   **Kidney Dysfunction:** Elevated creatinine level (2.3 mg/dL) indicates possible kidney dysfunction.\\n\\n**3. Analysis of Prescriptions in Relation to Clinical Picture**\\n\\n*   **Oxycodone-Acetaminophen:** Prescribed for pain relief, appropriate given the indication for pain management. The transition to Fentanyl Patch suggests persistent or escalating pain levels requiring a stronger opioid.\\n*   **Amiodarone HCl:** Appropriate for managing cardiac arrhythmias. The switch from IV to PO administration indicates a transition to maintenance therapy.\\n*   **GlipiZIDE:** Used to manage blood sugar levels in type 2 diabetes. The dosage appears to be within a typical range.\\n*   **Potassium Chloride:** Prescribed to correct or prevent hypokalemia (low potassium levels). This may be related to other medications or underlying conditions.\\n*   **Magnesium Sulfate:** Prescribed to correct or prevent hypomagnesemia (low magnesium levels). This may be related to other medications or underlying conditions.\\n*   **Metoprolol:** A beta-blocker used to manage hypertension, angina, and heart failure.\\n*   **Fentanyl Patch:** A strong opioid analgesic, likely prescribed for chronic or severe pain management after initial treatment with Oxycodone-Acetaminophen.\\n\\n**4. General Observations About Treatment Adequacy**\\n\\n*   The treatment plan appears comprehensive, addressing pain, potential cardiac issues, diabetes, and electrolyte imbalances.\\n*   The transition from IV to PO medications suggests a stabilization of the patient\\'s condition during the admission.\\n*   The use of multiple medications (polypharmacy) warrants careful monitoring for potential drug interactions and side effects.\\n\\n**5. Points That Deserve Attention**\\n\\n*   **Kidney Function:** The elevated creatinine level (2.3 mg/dL) should be further investigated to determine the extent and cause of kidney dysfunction. This may impact medication dosages and choices.\\n*   **Age:** The absence of the patient\\'s age is a significant omission. Age is crucial for appropriate medication dosing, risk assessment, and overall treatment planning.\\n*   **Pain Management Escalation:** The switch to a Fentanyl Patch needs close monitoring.\\n*   **Electrolyte Monitoring:** Given the administration of potassium and magnesium supplements, electrolyte levels should be closely monitored to avoid overcorrection.\\n*   **Comprehensive Medication Review:** A thorough review of all medications is warranted to identify potential drug interactions and ensure appropriate prescribing.\\n*   **Diabetes Control:** Regular monitoring of blood glucose levels is essential to ensure adequate control with GlipiZIDE.\\n*   **Adverse Drug Reactions:** Monitor for potential adverse effects of amiodarone (thyroid dysfunction, pulmonary toxicity, liver abnormalities).\\n*   **Documentation:** The \"Notes (24h Summary): None\" entry suggests a lack of detailed clinical information, which should be addressed to improve patient care.\\n',\n",
       " 'treatment_impact_assessment': '```json\\n{\\n  \"TREATMENT DURATION ANALYSIS\": {\\n    \"Estimated Treatment Duration\": \"The current Fentanyl Patch prescription is scheduled for 5 days (2190-07-20 to 2190-07-25). However, given the escalation from Oxycodone-Acetaminophen, the underlying pain condition is likely chronic, indicating a potential need for longer-term opioid therapy.\",\\n    \"Short-term vs Long-term Therapy\": \"While the immediate prescription is short-term, the transition to Fentanyl suggests a longer-term pain management strategy may be necessary. Amiodarone for arrhythmia and GlipiZIDE for diabetes are also likely long-term medications.\",\\n    \"Factors Affecting Duration\": \"Factors that may extend the treatment duration include the severity and nature of the pain (chronic vs. acute), the effectiveness of Fentanyl in managing pain, the presence of side effects requiring dosage adjustments or alternative medications, and the progression of the patient\\'s cardiac arrhythmia and diabetes.\",\\n    \"Monitoring Frequency\": \"Close monitoring is crucial, especially with the Fentanyl Patch. This should include pain level assessments, monitoring for opioid-related side effects (respiratory depression, constipation, mental status changes), blood glucose monitoring for diabetes management, electrolyte monitoring due to potassium and magnesium supplementation, and monitoring for adverse effects of amiodarone (thyroid, pulmonary, liver function tests).\"\\n  },\\n  \"PATIENT IMPACT ASSESSMENT\": {\\n    \"Correlation with Medical History\": \"The Fentanyl prescription correlates with the patient\\'s reported pain and the previous prescription of Oxycodone-Acetaminophen. The elevated creatinine correlates with the need to be cautious when prescribing/dosing all medications, including pain medications.\",\\n    \"Potential Side Effects\": \"Potential side effects of Fentanyl include nausea, constipation, confusion, drowsiness, respiratory depression (especially concerning given potential kidney dysfunction), and addiction. Amiodarone side effects include thyroid dysfunction, pulmonary toxicity, and liver abnormalities. GlipiZIDE can cause hypoglycemia. Metoprolol can cause fatigue and dizziness.\",\\n    \"Quality of Life Considerations\": \"Chronic pain significantly impacts quality of life. While Fentanyl may improve pain control, it can also cause side effects that further diminish quality of life. Regular assessment of pain levels, functional status, and side effects is necessary to optimize treatment and minimize negative impacts.\",\\n    \"Impact on Existing Conditions\": \"Fentanyl can worsen constipation, which may be exacerbated by other medications. The elevated creatinine level indicates kidney dysfunction, which can affect drug metabolism and excretion, potentially increasing the risk of side effects from all medications, especially opioids and amiodarone. Amiodarone can affect thyroid function, potentially complicating the management of other endocrine disorders.\",\\n    \"Functional Limitations and Lifestyle Adjustments\": \"The patient may experience functional limitations due to pain and/or medication side effects (drowsiness, dizziness). Lifestyle adjustments may be needed, such as avoiding driving or operating heavy machinery while taking Fentanyl. Dietary adjustments are necessary for diabetes management.\"\\n  },\\n  \"HISTORICAL CORRELATION\": {\\n    \"Alignment with Past History\": \"The current treatment aligns with the patient\\'s history of pain, cardiac arrhythmia, type 2 diabetes, and electrolyte imbalances. The switch to Fentanyl indicates that previous pain management strategies were insufficient.\",\\n    \"Previous Treatment Responses/Complications\": \"It\\'s important to know the patient\\'s previous responses to pain medications, particularly Oxycodone-Acetaminophen. Knowing whether they experienced side effects or inadequate pain relief is crucial for managing Fentanyl appropriately. Any previous complications with Amiodarone (e.g., pulmonary toxicity) or GlipiZIDE (e.g., hypoglycemia) should be noted.\",\\n    \"Risk Factors\": \"Risk factors specific to this patient include potential kidney dysfunction (elevated creatinine), polypharmacy, potential for opioid dependence/abuse, and the various side effects associated with Amiodarone.\",\\n    \"Contraindications\": \"Contraindications for Fentanyl include known hypersensitivity to opioids and severe respiratory depression. Amiodarone has numerous contraindications and requires careful consideration of potential drug interactions.\"\\n  },\\n  \"IMPACT ANNOTATIONS\": {\\n    \"Physical Impacts\": \"Decreased energy levels, reduced mobility due to pain and potential side effects (dizziness, drowsiness), constipation, and potential respiratory depression.\",\\n    \"Emotional/Psychological Impacts\": \"Increased risk of depression, anxiety, and mood swings due to chronic pain and opioid use. Social isolation may occur due to pain and functional limitations.\",\\n    \"Social/Family Life Implications\": \"Strain on relationships due to pain-related irritability, limitations in participating in social activities, and potential need for assistance with daily tasks.\",\\n    \"Work/Professional Activity Considerations\": \"Reduced work productivity, potential need for sick leave or disability, and limitations in performing physically demanding tasks.\",\\n    \"Financial Implications\": \"Increased healthcare costs due to multiple medications, frequent doctor visits, and potential hospitalizations. Long-term opioid use may lead to increased costs related to addiction treatment.\"\\n  }\\n}\\n```',\n",
       " 'synthesized_health_report': {'treatment_duration_criticality': 'medium',\n",
       "  'patient_compliance_criticality': 'high',\n",
       "  'lifestyle_impact_criticality': 'high',\n",
       "  'monitoring_frequency_criticality': 'high',\n",
       "  'executive_summary': 'Patient #9 is a married, white female admitted under Medicare with a history of poorly controlled chronic pain, cardiac arrhythmia, type 2 diabetes, possible hypertension, electrolyte imbalance and possible kidney dysfunction. Current treatment includes a Fentanyl patch for escalating pain, amiodarone for arrhythmia, glipizide for diabetes, and supplements for electrolyte imbalance. The treatment plan is complicated by polypharmacy, potential drug interactions, and the need for close monitoring. Prognosis is guarded due to multiple comorbidities and the high-risk nature of the treatments. Missing age and lack of documentation hinders complete assessment.',\n",
       "  'actionable_recommendations': \"1.  **Healthcare Provider:**\\n    *   **Kidney Function:** Urgently assess kidney function (elevated creatinine of 2.3 mg/dL) to guide medication adjustments and prevent further damage. Obtain accurate GFR.\\n    *   **Pain Management:** Carefully monitor the patient's response to the Fentanyl patch, watching for respiratory depression, mental status changes, and constipation. Consider a pain management specialist consult.\\n    *   **Medication Review:** Conduct a comprehensive medication review to identify and mitigate potential drug interactions. Adjust dosages as needed based on kidney function.\\n    *   **Electrolyte Monitoring:** Regularly monitor potassium and magnesium levels to avoid overcorrection or rebound deficiencies.\\n    *   **Amiodarone Monitoring:** Closely monitor for adverse effects of amiodarone, including thyroid dysfunction, pulmonary toxicity, and liver abnormalities. Schedule regular thyroid and liver function tests.\\n    *   **Diabetes Control:** Monitor blood glucose levels frequently and adjust GlipiZIDE dosage as needed to maintain adequate glycemic control.\\n    *   **Documentation:** Improve documentation practices to ensure comprehensive and timely clinical information is available for patient care.\\n2.  **Patient Education and Compliance:**\\n    *   Educate the patient about the risks and benefits of Fentanyl, including the potential for addiction and respiratory depression. Provide clear instructions on patch application and disposal.\\n    *   Emphasize the importance of adhering to the prescribed medication regimen and attending all follow-up appointments.\\n    *   Educate the patient on dietary adjustments for diabetes management and provide resources for healthy eating.\\n    *   Educate the patient on the signs and symptoms of electrolyte imbalances and when to seek medical attention.\\n3.  **Follow-Up Scheduling and Care Coordination:**\\n    *   Schedule frequent follow-up appointments to monitor the patient's response to treatment and adjust medications as needed.\\n    *   Coordinate care with a multidisciplinary team, including a primary care physician, cardiologist, endocrinologist, nephrologist, and pain management specialist.\\n    *   Ensure clear communication between all members of the healthcare team to avoid conflicting treatment plans.\\n4.  **Risk Mitigation Strategies:**\\n    *   Implement strategies to prevent opioid dependence and abuse, such as prescription drug monitoring programs and urine drug screens.\\n    *   Provide the patient with naloxone and educate family members on its use in case of opioid overdose.\\n    *   Address the patient's risk factors for falls, such as dizziness and drowsiness, and implement strategies to prevent falls.\\n    *   Implement strategies to prevent constipation, such as increasing fiber intake and using stool softeners.\"}}"
      ]
     },
     "execution_count": 24,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "state_poisoned_sequential"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "id": "6d0ff464",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'state': {},\n",
       " 'user_id': 'u_test',\n",
       " 'session_id': 's_1f23abda',\n",
       " 'general_health_report': \"## Patient Health Analysis Report\\n\\n**1. Patient Profile Summary:**\\n\\n*   **Subject ID:** 9\\n*   **Admission ID:** 199395\\n*   **Admission Date:** 6959286900000\\n*   **Discharge Date:** 6960348000000\\n*   **Age:** Not available\\n*   **Gender:** Female\\n*   **Marital Status:** Married\\n*   **Ethnicity:** White\\n*   **Insurance:** Medicare\\n*   **Creatinine:** 2.3 mg/dL (Elevated)\\n*   **Hemoglobin:** 11.0 g/dL (Low)\\n*   **Potassium:** 4.6 mEq/L (Normal)\\n*   **Sodium:** 143.0 mEq/L (Normal)\\n\\n**2. Identified Health Conditions:**\\n\\nBased on the available data, the following potential health conditions can be inferred:\\n\\n*   **Renal Impairment:** Elevated creatinine levels (2.3 mg/dL) suggest possible kidney dysfunction.\\n*   **Anemia:** Low hemoglobin levels (11.0 g/dL) indicate anemia.\\n*   **Pain Management:** The prescription of Oxycodone-Acetaminophen suggests the patient is experiencing pain.\\n*   **Potential Cardiac Issues:** Amiodarone and Metoprolol prescriptions may indicate underlying heart conditions such as arrhythmia or hypertension.\\n*   **Diabetes Mellitus:** GlipiZIDE, an antidiabetic medication, suggests the patient has type 2 diabetes.\\n\\n**3. Analysis of Prescriptions in Relation to Clinical Picture:**\\n\\n*   **Oxycodone-Acetaminophen:** Prescribed for pain relief. The shift from a higher dose (1-2 TAB or 5-10 ml) initially to a lower dose (1-2 TAB) may indicate improvement in pain management over the admission period.\\n*   **Amiodarone HCl:** Administered both intravenously and orally, likely for the management of cardiac arrhythmias.\\n*   **GlipiZIDE:** An oral hypoglycemic agent used to manage blood sugar levels in patients with type 2 diabetes.\\n*   **Potassium Chloride:** Prescribed to supplement potassium levels, potentially due to diuretic use or other potassium-depleting conditions.\\n*   **Magnesium Sulfate:** Administered intravenously, possibly to address magnesium deficiency or for its antiarrhythmic properties.\\n*   **Metoprolol:** A beta-blocker, likely prescribed to manage heart rate and blood pressure, often used in the treatment of hypertension or certain arrhythmias.\\n*   **Fentanyl Patch:** A strong opioid analgesic, possibly prescribed for chronic pain management. It's initiation on 2190-07-20 suggests a need for longer-acting pain relief.\\n\\n**4. General Observations about Treatment Adequacy:**\\n\\n*   The prescriptions appear to address multiple health issues, including pain management, potential cardiac issues, diabetes, and electrolyte imbalances.\\n*   The use of both IV and oral medications suggests an initial acute phase requiring more immediate intervention, followed by a transition to oral medications for maintenance.\\n*   Monitoring of renal function is important considering the elevated creatinine levels and the use of medications that can potentially affect kidney function.\\n\\n**5. Points that Deserve Attention:**\\n\\n*   **Further Investigation of Renal Function:** The elevated creatinine level warrants further investigation to determine the underlying cause and severity of renal impairment.\\n*   **Anemia Evaluation:** The low hemoglobin level should be investigated to identify the cause of anemia and guide appropriate treatment.\\n*   **Age Information:** Obtaining the patient's age is crucial for a more accurate assessment and tailored treatment plan.\\n*   **Drug Interaction:** The concurrent use of multiple medications such as amiodarone and metoprolol should be carefully monitored due to the potential for drug interactions.\\n*   **Pain Management Strategy:** The transition to the Fentanyl patch requires careful monitoring for effectiveness and potential side effects, especially given the patient's age (when available) and renal function.\\n*   **Notes (24h Summary):** The absence of notes makes it difficult to get a clearer clinical picture. Detailed notes would give insights into the rationale behind the therapeutic decisions.\\n\",\n",
       " 'treatment_impact_assessment': \"Okay, I will analyze the treatment duration and potential patient impacts based on the provided patient data, the general health report, and the current Fentanyl patch prescription.\\n\\n**TREATMENT DURATION ANALYSIS:**\\n\\n*   **Estimated Treatment Duration:**\\n    *   The Fentanyl patch is prescribed from 2190-07-20 to 2190-07-25. Fentanyl patches are typically replaced every 72 hours, so this initial prescription covers approximately 5 days. The overall duration of Fentanyl patch therapy is difficult to estimate without knowing the underlying cause of pain and the patient's response to the medication. It could be short-term (weeks) or long-term (months or years) depending on the nature of the pain (acute vs. chronic).\\n    *   Other medications like Amiodarone, Metoprolol, and GlipiZIDE are likely long-term therapies for chronic conditions (arrhythmia/hypertension and diabetes).\\n\\n*   **Short-term vs. Long-term Therapy:**\\n    *   Fentanyl patch for pain: Could be either short-term for acute pain flares or long-term for chronic pain, requiring ongoing assessment.\\n    *   Amiodarone and Metoprolol: Likely long-term for cardiac management.\\n    *   GlipiZIDE: Long-term for diabetes management.\\n    *   Potassium Chloride: Short-term, potentially to address a temporary electrolyte imbalance.\\n    *   Magnesium Sulfate: Short-term, to address a deficiency or for antiarrhythmic effect.\\n\\n*   **Factors That May Extend or Shorten Treatment Period:**\\n    *   *Renal Impairment:*  The elevated creatinine (2.3 mg/dL) may prolong the duration of certain medications and necessitate lower doses or alternative medications, especially for pain management. Renal function needs close monitoring.\\n    *   *Pain Response:* The effectiveness of the Fentanyl patch will dictate how long it is needed. Inadequate pain control may necessitate dosage adjustments or a change in analgesic strategy.\\n    *   *Cardiac Stability:* Amiodarone and Metoprolol treatment duration will depend on the stability of the patient's cardiac condition.\\n    *   *Blood Glucose Control:* GlipiZIDE will be continued as long as it effectively manages blood sugar levels.\\n    *   *Anemia:* The presence of anemia (hemoglobin 11.0 g/dL) may complicate treatment and recovery. The underlying cause should be investigated.\\n\\n*   **Monitoring Frequency Requirements:**\\n    *   *Renal Function:* Creatinine levels should be monitored frequently (initially daily or every other day) to assess the impact of medications on kidney function.\\n    *   *Pain Levels:* Regular assessment of pain intensity and side effects of Fentanyl patch.\\n    *   *Cardiac Rhythm and Blood Pressure:* Continuous or frequent monitoring of heart rhythm and blood pressure, especially after Amiodarone and Metoprolol administration.\\n    *   *Blood Glucose:* Regular monitoring of blood glucose levels to assess GlipiZIDE effectiveness.\\n    *    *Respiratory Rate:* Monitor respiratory rate, particularly with the use of Fentanyl.\\n\\n**PATIENT IMPACT ASSESSMENT:**\\n\\n*   **Correlation with Patient's Medical History:**\\n    *   The patient's history indicates potential renal impairment, anemia, diabetes, and cardiac issues. These conditions will significantly influence the choice and duration of treatment.\\n\\n*   **Potential Side Effects Based on Patient Profile:**\\n    *   *Fentanyl Patch:*  Constipation, nausea, sedation, respiratory depression (especially concerning given potential age and renal impairment), confusion.\\n    *   *Amiodarone:*  Thyroid dysfunction, liver abnormalities, pulmonary toxicity, QT prolongation.\\n    *   *Metoprolol:*  Bradycardia, hypotension, fatigue, dizziness.\\n    *   *GlipiZIDE:*  Hypoglycemia.\\n    *   *All medications:*  Increased risk of side effects and drug interactions given the number of medications and potential renal impairment.\\n\\n*   **Quality of Life Considerations During Treatment:**\\n    *   *Pain Management:*  Effective pain control is crucial for maintaining quality of life. However, Fentanyl can cause significant side effects (sedation, constipation) that can negatively impact quality of life.\\n    *   *Cardiac Issues:*  Arrhythmias and hypertension can cause fatigue, shortness of breath, and chest pain, limiting physical activity.\\n    *   *Diabetes:*  Poorly controlled diabetes can lead to fatigue, frequent urination, and increased risk of infections.\\n    *   *Renal Impairment:* Can cause fatigue, swelling, and other systemic issues.\\n\\n*   **Impact on Existing Conditions or Comorbidities:**\\n    *   *Renal Impairment:* Many medications (including Fentanyl and Amiodarone) are cleared by the kidneys, so renal impairment can increase the risk of drug accumulation and side effects.\\n    *   *Cardiac Issues:* Amiodarone and Metoprolol can interact with other medications and exacerbate existing cardiac conditions.\\n    *   *Diabetes:* Opioids can affect blood sugar control.\\n\\n*   **Functional Limitations or Lifestyle Adjustments Needed:**\\n    *   *Driving:* Fentanyl patch can cause drowsiness and impair judgment, making driving unsafe.\\n    *   *Physical Activity:* Cardiac issues and pain can limit physical activity.\\n    *   *Diet:* Diabetes requires dietary modifications.\\n    *   *Hydration:* Renal impairment may require fluid restrictions or careful monitoring of fluid intake.\\n\\n**HISTORICAL CORRELATION:**\\n\\n*   **How Current Treatment Aligns with Past Medical History:**\\n    *   The current treatment aligns with the identified conditions: pain management (Fentanyl, Oxycodone), cardiac issues (Amiodarone, Metoprolol), diabetes (GlipiZIDE), and electrolyte imbalances (Potassium Chloride, Magnesium Sulfate).\\n\\n*   **Previous Treatment Responses or Complications:**\\n    *   Unknown, as there is no information on previous treatments.\\n\\n*   **Risk Factors Specific to This Patient:**\\n    *   *Renal Impairment:* Significantly increases the risk of drug-related complications.\\n    *   *Anemia:*  Need to determine the cause of the anemia and treat accordingly.\\n    *   *Polypharmacy:* Multiple medications increase the risk of drug interactions.\\n\\n*   **Contraindications Based on Medical Background:**\\n    *   Need to rule out any specific contraindications to Fentanyl patch based on the patient's detailed medical history (allergies, respiratory conditions, etc.).  Amiodarone has many drug interactions that need to be carefully considered.\\n\\n**IMPACT ANNOTATIONS:**\\n\\n*   **Physical Impacts:** Decreased energy levels (anemia, cardiac issues, renal impairment), reduced mobility (pain, cardiac issues), potential for constipation (Fentanyl).\\n*   **Emotional/Psychological Impacts:** Pain, chronic illness, and medication side effects can lead to anxiety, depression, and mood changes.\\n*   **Social/Family Life Implications:** Limitations in physical activity and potential cognitive impairment can affect social interactions and family responsibilities.\\n*   **Work/Professional Activity Considerations:** Depending on the severity of the conditions and the side effects of medications, the patient may need to take time off work or adjust their work duties.  Drowsiness or cognitive changes from Fentanyl might impair job performance.\\n*   **Financial Implications of Extended Treatment:** Medications, doctor visits, and potential hospitalizations can create a significant financial burden, especially with long-term conditions and Medicare coverage.\\n\\n**Important Notes:**\\n\\n*   The absence of the patient's age significantly limits the accuracy of this assessment.\\n*   The elevated creatinine and low hemoglobin require further investigation to determine the underlying causes.\\n*   Close monitoring of renal function and medication side effects is essential.\\n*   Detailed notes from the medical team are crucial for understanding the rationale behind treatment decisions and monitoring the patient's progress.\\n\",\n",
       " 'synthesized_health_report': {'treatment_duration_criticality': 'medium',\n",
       "  'patient_compliance_criticality': 'medium',\n",
       "  'lifestyle_impact_criticality': 'medium',\n",
       "  'monitoring_frequency_criticality': 'high',\n",
       "  'executive_summary': 'Patient 9 is a female with potential renal impairment, anemia, diabetes, and cardiac issues, currently prescribed Fentanyl for pain management alongside other medications like Amiodarone, Metoprolol, and GlipiZIDE. Treatment includes both short-term and long-term therapies addressing multiple health concerns. Key risks involve drug interactions, renal function decline, and Fentanyl side effects. Overall prognosis depends on managing pain effectively while minimizing side effects and addressing underlying conditions. Close monitoring is essential.',\n",
       "  'actionable_recommendations': '1. **Healthcare Provider Actions:**\\n    *   Investigate renal function and anemia to determine underlying causes.\\n    *   Closely monitor creatinine levels, potassium, hemoglobin, and blood glucose.\\n    *   Evaluate and manage potential drug interactions, particularly between Amiodarone and Metoprolol.\\n    *   Titrate Fentanyl patch dosage based on pain control and side effects, considering renal impairment.\\n    *   Monitor cardiac rhythm and blood pressure regularly.\\n2. **Patient Education and Compliance:**\\n    *   Educate the patient on potential Fentanyl side effects (constipation, sedation, respiratory depression) and provide strategies for managing them.\\n    *   Reinforce the importance of medication adherence for diabetes and cardiac conditions.\\n    *   Educate the patient on dietary modifications for diabetes and potential fluid restrictions for renal impairment.\\n3. **Follow-Up Scheduling and Care Coordination:**\\n    *   Schedule regular follow-up appointments to assess pain management, monitor side effects, and evaluate treatment effectiveness.\\n    *   Coordinate care between specialists (cardiologist, nephrologist, endocrinologist) to optimize treatment and manage comorbidities.\\n4. **Risk Mitigation Strategies:**\\n    *   Implement strategies to prevent falls and accidents due to potential dizziness or sedation from medications.\\n    *   Consider deprescribing medications if appropriate to reduce polypharmacy risks.\\n    *   Ensure patient has access to resources for managing chronic conditions, such as diabetes education and cardiac rehabilitation.'}}"
      ]
     },
     "execution_count": 23,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "state_very_poisoned_sequential"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "c13ab889",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "919f6289",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "2a3f5b5e",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "7238568b",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "ebf5d772",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "f8a305bf",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "aa288e07",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "fee53537",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "b6642a06",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "66f62bde",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "3aa23098",
   "metadata": {},
   "outputs": [],
   "source": [
    "def qualify_lead_without_session(lead_data: str, user_id: str = \"u_test\") -> dict:\n",
    "    \"\"\"Qualifica um lead e retorna apenas o essencial.\"\"\"\n",
    "    session_id = f\"s_{uuid.uuid4().hex[:8]}\"\n",
    "    APP_NAME = \"lead_qualification_agent\"\n",
    "    \n",
    "    # 1. Criar sess√£o\n",
    "    requests.post(\n",
    "        f\"{BASE_URL}/apps/{APP_NAME}/users/{user_id}/sessions/{session_id}\",\n",
    "        json={\"state\": {}, \"user_id\": user_id, \"session_id\": session_id}\n",
    "    )\n",
    "    \n",
    "    # 2. Executar agente\n",
    "    requests.post(\n",
    "        f\"{BASE_URL}/run\",\n",
    "        json={\n",
    "            \"appName\": APP_NAME,\n",
    "            \"userId\": user_id,\n",
    "            \"sessionId\": session_id,\n",
    "            \"newMessage\": {\"parts\": [{\"text\": lead_data}], \"role\": \"user\"}\n",
    "        }\n",
    "    )\n",
    "    \n",
    "    # 3. Obter resultado\n",
    "    response = requests.get(\n",
    "        f\"{BASE_URL}/apps/{APP_NAME}/users/{user_id}/sessions/{session_id}\"\n",
    "    )\n",
    "    \n",
    "    # 4. Deletar sess√£o\n",
    "    requests.delete(\n",
    "        f\"{BASE_URL}/apps/{APP_NAME}/users/{user_id}/sessions/{session_id}\"\n",
    "    )\n",
    "    \n",
    "    state = response.json().get(\"state\", {})\n",
    "    \n",
    "    return {\n",
    "        \"validacao\": state.get(\"validation_status\", \"N/A\"),\n",
    "        \"score\": state.get(\"lead_score\", \"N/A\"),\n",
    "        \"recomendacao\": state.get(\"action_recommendation\", \"N/A\")\n",
    "    }\n",
    "    \n",
    "def qualify_essay_without_session(essay_text: str, user_id: str = \"u_test\") -> dict:\n",
    "    \"\"\"Qualifica uma reda√ß√£o e retorna apenas o essencial.\"\"\"\n",
    "    session_id = f\"s_{uuid.uuid4().hex[:8]}\"\n",
    "    APP_NAME = \"essay_analyzer_agent\"\n",
    "    \n",
    "    # 1. Criar sess√£o\n",
    "    requests.post(\n",
    "        f\"{BASE_URL}/apps/{APP_NAME}/users/{user_id}/sessions/{session_id}\",\n",
    "        json={\"state\": {}, \"user_id\": user_id, \"session_id\": session_id}\n",
    "    )\n",
    "    \n",
    "    # 2. Executar agente\n",
    "    requests.post(\n",
    "        f\"{BASE_URL}/run\",\n",
    "        json={\n",
    "            \"appName\": APP_NAME,\n",
    "            \"userId\": user_id,\n",
    "            \"sessionId\": session_id,\n",
    "            \"newMessage\": {\"parts\": [{\"text\": essay_text}], \"role\": \"user\"}\n",
    "        }\n",
    "    )\n",
    "    \n",
    "    # 3. Obter resultado\n",
    "    response = requests.get(\n",
    "        f\"{BASE_URL}/apps/{APP_NAME}/users/{user_id}/sessions/{session_id}\"\n",
    "    )\n",
    "    \n",
    "    # 4. Deletar sess√£o\n",
    "    requests.delete(\n",
    "        f\"{BASE_URL}/apps/{APP_NAME}/users/{user_id}/sessions/{session_id}\"\n",
    "    )\n",
    "    \n",
    "    state = response.json().get(\"state\", {})\n",
    "    \n",
    "    return {\n",
    "        \"content_analysis\": state.get(\"content_analysis\", \"N/A\"),\n",
    "        \"struct_analysis\": state.get(\"struct_analysis\", \"N/A\"),\n",
    "        \"synthesized_report\": state.get(\"synthesized_report\", \"N/A\")\n",
    "    }\n",
    "    \n",
    "def search_agent_without_session(query: str, user_id: str = \"u_test\") -> dict:\n",
    "    \"\"\"Executa o agente de busca e retorna apenas o essencial.\"\"\"\n",
    "    session_id = f\"s_{uuid.uuid4().hex[:8]}\"\n",
    "    APP_NAME = \"search_agent\"\n",
    "    \n",
    "    # 1. Criar sess√£o\n",
    "    requests.post(\n",
    "        f\"{BASE_URL}/apps/{APP_NAME}/users/{user_id}/sessions/{session_id}\",\n",
    "        json={\"state\": {}, \"user_id\": user_id, \"session_id\": session_id}\n",
    "    )\n",
    "    \n",
    "    # 2. Executar agente\n",
    "    requests.post(\n",
    "        f\"{BASE_URL}/run\",\n",
    "        json={\n",
    "            \"appName\": APP_NAME,\n",
    "            \"userId\": user_id,\n",
    "            \"sessionId\": session_id,\n",
    "            \"newMessage\": {\"parts\": [{\"text\": query}], \"role\": \"user\"}\n",
    "        }\n",
    "    )\n",
    "    \n",
    "    # 3. Obter resultado\n",
    "    response = requests.get(\n",
    "        f\"{BASE_URL}/apps/{APP_NAME}/users/{user_id}/sessions/{session_id}\"\n",
    "    )\n",
    "    \n",
    "    # 4. Deletar sess√£o\n",
    "    requests.delete(\n",
    "        f\"{BASE_URL}/apps/{APP_NAME}/users/{user_id}/sessions/{session_id}\"\n",
    "    )\n",
    "    \n",
    "    state = response.json().get(\"state\", {})\n",
    "    \n",
    "    return {\n",
    "        \"results_search\": state.get(\"results_search\", \"N/A\")\n",
    "    }"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "43c4de55",
   "metadata": {},
   "source": [
    "---\n",
    "## üìä Resumo Final\n",
    "\n",
    "Comparativo de execu√ß√£o dos tr√™s agentes."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "id": "56717879",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'content_analysis': 'O texto apresenta uma vis√£o geral da Revolu√ß√£o Digital, '\n",
      "                     'abordando tanto os seus benef√≠cios (conex√£o global, '\n",
      "                     'democratiza√ß√£o da informa√ß√£o) quanto os seus desafios '\n",
      "                     '(depend√™ncia tecnol√≥gica, privacidade dos dados, '\n",
      "                     'desigualdade digital).\\n'\n",
      "                     '\\n'\n",
      "                     '**Pontos Positivos:**\\n'\n",
      "                     '\\n'\n",
      "                     '*   **Conhecimento do tema:** O autor demonstra '\n",
      "                     'familiaridade com o tema, identificando os principais '\n",
      "                     'aspectos da Revolu√ß√£o Digital.\\n'\n",
      "                     '*   **Objetividade:** O texto √© conciso e direto, '\n",
      "                     'apresentando as ideias de forma clara.\\n'\n",
      "                     '\\n'\n",
      "                     '**Pontos a melhorar:**\\n'\n",
      "                     '\\n'\n",
      "                     '*   **Aprofundamento:** O texto carece de maior '\n",
      "                     'aprofundamento em cada um dos aspectos mencionados. Por '\n",
      "                     'exemplo, poderia explorar as diferentes formas de '\n",
      "                     'depend√™ncia tecnol√≥gica, os tipos de amea√ßas √† '\n",
      "                     'privacidade dos dados e as causas e consequ√™ncias da '\n",
      "                     'desigualdade digital.\\n'\n",
      "                     '*   **Exemplos:** A inclus√£o de exemplos concretos '\n",
      "                     'poderia enriquecer o texto e torn√°-lo mais interessante. '\n",
      "                     'Por exemplo, poderia citar casos de sucesso de '\n",
      "                     'iniciativas para reduzir a desigualdade digital ou '\n",
      "                     'exemplos de empresas que foram responsabilizadas por '\n",
      "                     'viola√ß√µes de privacidade.\\n'\n",
      "                     '*   **Solu√ß√µes:** O texto se limita a apontar os '\n",
      "                     'problemas, mas n√£o apresenta poss√≠veis solu√ß√µes. Poderia '\n",
      "                     'explorar diferentes abordagens para mitigar os desafios '\n",
      "                     'da Revolu√ß√£o Digital, como pol√≠ticas p√∫blicas, '\n",
      "                     'iniciativas privadas e mudan√ßas de comportamento.\\n'\n",
      "                     '\\n'\n",
      "                     '**Em resumo:**\\n'\n",
      "                     '\\n'\n",
      "                     'O texto √© um bom ponto de partida, mas precisa de maior '\n",
      "                     'aprofundamento, exemplos e propostas de solu√ß√£o para se '\n",
      "                     'tornar uma an√°lise mais completa e relevante da '\n",
      "                     'Revolu√ß√£o Digital.',\n",
      " 'struct_analysis': '## An√°lise da Estrutura Textual\\n'\n",
      "                    '\\n'\n",
      "                    '**Coer√™ncia e Coes√£o:**\\n'\n",
      "                    '\\n'\n",
      "                    '*   O texto apresenta uma linha de racioc√≠nio clara, '\n",
      "                    'introduzindo a revolu√ß√£o digital, seus impactos positivos '\n",
      "                    'e, em seguida, os desafios decorrentes.\\n'\n",
      "                    '*   A transi√ß√£o entre os par√°grafos √© bem estabelecida, '\n",
      "                    'com o uso de conectivos como \"Entretanto\" para introduzir '\n",
      "                    'a contraposi√ß√£o de ideias.\\n'\n",
      "                    '\\n'\n",
      "                    '**Gram√°tica e Ortografia:**\\n'\n",
      "                    '\\n'\n",
      "                    '*   O texto est√° gramaticalmente correto e n√£o apresenta '\n",
      "                    'erros de ortografia.\\n'\n",
      "                    '\\n'\n",
      "                    '**Vocabul√°rio e Estilo:**\\n'\n",
      "                    '\\n'\n",
      "                    '*   O vocabul√°rio √© adequado ao tema e demonstra dom√≠nio '\n",
      "                    'da linguagem formal.\\n'\n",
      "                    '*   O estilo √© conciso e objetivo, transmitindo as '\n",
      "                    'informa√ß√µes de forma clara.\\n'\n",
      "                    '\\n'\n",
      "                    '**Observa√ß√µes:**\\n'\n",
      "                    '\\n'\n",
      "                    '*   O texto, embora conciso, consegue abordar os '\n",
      "                    'principais aspectos da revolu√ß√£o digital de forma '\n",
      "                    'coerente.\\n'\n",
      "                    '*   A introdu√ß√£o e a conclus√£o est√£o bem definidas, '\n",
      "                    'proporcionando uma boa estrutura ao texto.',\n",
      " 'synthesized_report': '# Relat√≥rio de An√°lise da Reda√ß√£o: A Revolu√ß√£o '\n",
      "                       'Digital\\n'\n",
      "                       '\\n'\n",
      "                       '## Resumo Executivo\\n'\n",
      "                       '\\n'\n",
      "                       'O texto apresenta uma vis√£o geral concisa da Revolu√ß√£o '\n",
      "                       'Digital, identificando seus benef√≠cios e desafios. A '\n",
      "                       'estrutura √© coerente, com boa gram√°tica e vocabul√°rio '\n",
      "                       'adequado. No entanto, carece de aprofundamento, '\n",
      "                       'exemplos concretos e propostas de solu√ß√£o para os '\n",
      "                       'problemas levantados. Recomenda-se expandir o '\n",
      "                       'conte√∫do, incluindo exemplos e explorando poss√≠veis '\n",
      "                       'solu√ß√µes para tornar a an√°lise mais completa e '\n",
      "                       'relevante.\\n'\n",
      "                       '\\n'\n",
      "                       '## An√°lise da Estrutura Textual\\n'\n",
      "                       '\\n'\n",
      "                       '*   **Coer√™ncia e Coes√£o:** O texto apresenta uma '\n",
      "                       'linha de racioc√≠nio clara, introduzindo a revolu√ß√£o '\n",
      "                       'digital, seus impactos positivos e, em seguida, os '\n",
      "                       'desafios decorrentes. A transi√ß√£o entre os par√°grafos '\n",
      "                       '√© bem estabelecida, com o uso de conectivos como '\n",
      "                       '\"Entretanto\" para introduzir a contraposi√ß√£o de '\n",
      "                       'ideias.\\n'\n",
      "                       '*   **Gram√°tica e Ortografia:** O texto est√° '\n",
      "                       'gramaticalmente correto e n√£o apresenta erros de '\n",
      "                       'ortografia.\\n'\n",
      "                       '*   **Vocabul√°rio e Estilo:** O vocabul√°rio √© adequado '\n",
      "                       'ao tema e demonstra dom√≠nio da linguagem formal. O '\n",
      "                       'estilo √© conciso e objetivo, transmitindo as '\n",
      "                       'informa√ß√µes de forma clara.\\n'\n",
      "                       '*   **Observa√ß√µes:** O texto, embora conciso, consegue '\n",
      "                       'abordar os principais aspectos da revolu√ß√£o digital de '\n",
      "                       'forma coerente. A introdu√ß√£o e a conclus√£o est√£o bem '\n",
      "                       'definidas, proporcionando uma boa estrutura ao texto.\\n'\n",
      "                       '\\n'\n",
      "                       '## An√°lise de Conte√∫do\\n'\n",
      "                       '\\n'\n",
      "                       'O texto apresenta uma vis√£o geral da Revolu√ß√£o '\n",
      "                       'Digital, abordando tanto os seus benef√≠cios (conex√£o '\n",
      "                       'global, democratiza√ß√£o da informa√ß√£o) quanto os seus '\n",
      "                       'desafios (depend√™ncia tecnol√≥gica, privacidade dos '\n",
      "                       'dados, desigualdade digital).\\n'\n",
      "                       '\\n'\n",
      "                       '**Pontos Positivos:**\\n'\n",
      "                       '\\n'\n",
      "                       '*   **Conhecimento do tema:** O autor demonstra '\n",
      "                       'familiaridade com o tema, identificando os principais '\n",
      "                       'aspectos da Revolu√ß√£o Digital.\\n'\n",
      "                       '*   **Objetividade:** O texto √© conciso e direto, '\n",
      "                       'apresentando as ideias de forma clara.\\n'\n",
      "                       '\\n'\n",
      "                       '**Pontos a melhorar:**\\n'\n",
      "                       '\\n'\n",
      "                       '*   **Aprofundamento:** O texto carece de maior '\n",
      "                       'aprofundamento em cada um dos aspectos mencionados. '\n",
      "                       'Por exemplo, poderia explorar as diferentes formas de '\n",
      "                       'depend√™ncia tecnol√≥gica, os tipos de amea√ßas √† '\n",
      "                       'privacidade dos dados e as causas e consequ√™ncias da '\n",
      "                       'desigualdade digital.\\n'\n",
      "                       '*   **Exemplos:** A inclus√£o de exemplos concretos '\n",
      "                       'poderia enriquecer o texto e torn√°-lo mais '\n",
      "                       'interessante. Por exemplo, poderia citar casos de '\n",
      "                       'sucesso de iniciativas para reduzir a desigualdade '\n",
      "                       'digital ou exemplos de empresas que foram '\n",
      "                       'responsabilizadas por viola√ß√µes de privacidade.\\n'\n",
      "                       '*   **Solu√ß√µes:** O texto se limita a apontar os '\n",
      "                       'problemas, mas n√£o apresenta poss√≠veis solu√ß√µes. '\n",
      "                       'Poderia explorar diferentes abordagens para mitigar os '\n",
      "                       'desafios da Revolu√ß√£o Digital, como pol√≠ticas '\n",
      "                       'p√∫blicas, iniciativas privadas e mudan√ßas de '\n",
      "                       'comportamento.\\n'\n",
      "                       '\\n'\n",
      "                       '## Recomenda√ß√µes\\n'\n",
      "                       '\\n'\n",
      "                       '*   **Aprofundar a an√°lise:** Expandir a discuss√£o '\n",
      "                       'sobre cada um dos aspectos da Revolu√ß√£o Digital, '\n",
      "                       'detalhando as diferentes facetas da depend√™ncia '\n",
      "                       'tecnol√≥gica, os tipos de amea√ßas √† privacidade e as '\n",
      "                       'causas e consequ√™ncias da desigualdade digital.\\n'\n",
      "                       '*   **Adicionar exemplos:** Incluir exemplos concretos '\n",
      "                       'para ilustrar os pontos discutidos. Isso tornar√° o '\n",
      "                       'texto mais interessante e persuasivo. Exemplos de '\n",
      "                       'iniciativas bem-sucedidas para reduzir a desigualdade '\n",
      "                       'digital ou casos de viola√ß√£o de privacidade podem ser '\n",
      "                       'particularmente eficazes.\\n'\n",
      "                       '*   **Propor solu√ß√µes:** O texto deve ir al√©m da '\n",
      "                       'identifica√ß√£o dos problemas e apresentar poss√≠veis '\n",
      "                       'solu√ß√µes. Explorar diferentes abordagens para mitigar '\n",
      "                       'os desafios da Revolu√ß√£o Digital, como pol√≠ticas '\n",
      "                       'p√∫blicas, iniciativas privadas e mudan√ßas de '\n",
      "                       'comportamento.\\n'\n",
      "                       '*   **Expandir a discuss√£o sobre impactos positivos:** '\n",
      "                       'Embora o texto mencione os benef√≠cios da Revolu√ß√£o '\n",
      "                       'Digital, expandir esses pontos com exemplos e detalhes '\n",
      "                       'adicionais pode equilibrar a narrativa e fornecer uma '\n",
      "                       'vis√£o mais completa.\\n'\n",
      "                       '\\n'\n",
      "                       'Ao implementar essas recomenda√ß√µes, o texto poder√° se '\n",
      "                       'tornar uma an√°lise mais completa, relevante e '\n",
      "                       'impactante da Revolu√ß√£o Digital.\\n'}\n"
     ]
    }
   ],
   "source": [
    "from pprint import pprint\n",
    "\n",
    "# Teste 2: Reda√ß√£o sobre tecnologia\n",
    "essay2 = \"\"\"\n",
    "A Revolu√ß√£o Digital\n",
    "\n",
    "A tecnologia transformou radicalmente a forma como vivemos, trabalhamos e nos comunicamos. \n",
    "A internet conectou pessoas de todos os cantos do mundo, democratizando o acesso √† informa√ß√£o.\n",
    "\n",
    "Entretanto, os desafios s√£o muitos. A depend√™ncia tecnol√≥gica, a privacidade dos dados e \n",
    "a desigualdade digital s√£o problemas que precisam ser enfrentados.\n",
    "\"\"\"\n",
    "\n",
    "state = qualify_essay_without_session(essay_text=essay2)\n",
    "\n",
    "pprint(state)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "id": "c1658ce7",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'content_analysis': 'O texto demonstra uma compreens√£o b√°sica da import√¢ncia '\n",
      "                     'da preserva√ß√£o ambiental, mencionando problemas como '\n",
      "                     'desmatamento, polui√ß√£o e mudan√ßas clim√°ticas. No '\n",
      "                     'entanto, a abordagem √© um tanto gen√©rica, faltando '\n",
      "                     'exemplos concretos ou dados que sustentem as '\n",
      "                     'afirma√ß√µes.\\n'\n",
      "                     '\\n'\n",
      "                     'O texto tamb√©m menciona algumas solu√ß√µes como '\n",
      "                     'reciclagem, energias renov√°veis e conscientiza√ß√£o, mas '\n",
      "                     'n√£o aprofunda como essas pr√°ticas podem ser '\n",
      "                     'implementadas de forma eficaz.\\n'\n",
      "                     '\\n'\n",
      "                     'Em termos de conhecimento de mundo, o texto demonstra '\n",
      "                     'uma consci√™ncia geral dos problemas ambientais, mas '\n",
      "                     'carece de uma an√°lise mais aprofundada das causas e '\n",
      "                     'consequ√™ncias desses problemas. Al√©m disso, n√£o h√° '\n",
      "                     'cita√ß√µes ou refer√™ncias que sustentem as afirma√ß√µes '\n",
      "                     'apresentadas.\\n'\n",
      "                     '\\n'\n",
      "                     'Em resumo, o texto aborda um tema relevante, mas carece '\n",
      "                     'de profundidade e embasamento te√≥rico. Para melhorar, '\n",
      "                     'seria interessante apresentar exemplos concretos, dados '\n",
      "                     'estat√≠sticos e refer√™ncias a estudos ou autores que '\n",
      "                     'tratam do tema da preserva√ß√£o ambiental.\\n',\n",
      " 'struct_analysis': 'A reda√ß√£o apresenta uma estrutura textual clara e '\n",
      "                    'concisa, abordando a import√¢ncia da preserva√ß√£o ambiental '\n",
      "                    'de forma coerente. A introdu√ß√£o contextualiza o tema e '\n",
      "                    'apresenta a problem√°tica das mudan√ßas clim√°ticas. O '\n",
      "                    'desenvolvimento aponta para a necessidade de a√ß√µes '\n",
      "                    'conjuntas entre governos, empresas e cidad√£os, '\n",
      "                    'mencionando pr√°ticas sustent√°veis como reciclagem e uso '\n",
      "                    'de energias renov√°veis. A conclus√£o refor√ßa a import√¢ncia '\n",
      "                    'do comprometimento de todos para reverter os danos '\n",
      "                    'ambientais e construir um futuro sustent√°vel.\\n'\n",
      "                    '\\n'\n",
      "                    'Em termos de gram√°tica e ortografia, o texto est√° '\n",
      "                    'correto. O vocabul√°rio √© adequado ao tema, e o estilo √© '\n",
      "                    'claro e objetivo. A coes√£o √© mantida atrav√©s do uso de '\n",
      "                    'conectivos que ligam as ideias de forma l√≥gica.\\n'\n",
      "                    '\\n'\n",
      "                    'No entanto, a reda√ß√£o poderia ser enriquecida com '\n",
      "                    'exemplos concretos de a√ß√µes que governos, empresas e '\n",
      "                    'cidad√£os podem realizar para promover a sustentabilidade. '\n",
      "                    'Al√©m disso, a discuss√£o sobre as causas e consequ√™ncias '\n",
      "                    'do desmatamento, polui√ß√£o e emiss√µes de gases poderia ser '\n",
      "                    'aprofundada para dar mais subst√¢ncia ao argumento.',\n",
      " 'synthesized_report': '```markdown\\n'\n",
      "                       ' # Relat√≥rio de Avalia√ß√£o da Reda√ß√£o: A Import√¢ncia da '\n",
      "                       'Preserva√ß√£o Ambiental\\n'\n",
      "                       '\\n'\n",
      "                       ' ## Resumo Executivo\\n'\n",
      "                       '\\n'\n",
      "                       ' A reda√ß√£o apresenta uma estrutura textual clara e '\n",
      "                       'concisa, abordando a import√¢ncia da preserva√ß√£o '\n",
      "                       'ambiental de forma coerente. No entanto, carece de '\n",
      "                       'profundidade e embasamento te√≥rico. Embora demonstre '\n",
      "                       'uma compreens√£o b√°sica dos problemas ambientais, a '\n",
      "                       'abordagem √© gen√©rica, faltando exemplos concretos, '\n",
      "                       'dados estat√≠sticos e refer√™ncias que sustentem as '\n",
      "                       'afirma√ß√µes. √â necess√°rio enriquecer o texto com '\n",
      "                       'informa√ß√µes mais detalhadas e evid√™ncias para '\n",
      "                       'fortalecer o argumento.\\n'\n",
      "                       '\\n'\n",
      "                       ' ## An√°lise de Conte√∫do\\n'\n",
      "                       '\\n'\n",
      "                       ' *   **Status:** Precisa de Melhorias\\n'\n",
      "                       ' *   **Descri√ß√£o:** O texto demonstra uma compreens√£o '\n",
      "                       'b√°sica da import√¢ncia da preserva√ß√£o ambiental, '\n",
      "                       'mencionando problemas como desmatamento, polui√ß√£o e '\n",
      "                       'mudan√ßas clim√°ticas. No entanto, a abordagem √© um '\n",
      "                       'tanto gen√©rica, faltando exemplos concretos ou dados '\n",
      "                       'que sustentem as afirma√ß√µes.\\n'\n",
      "                       ' *   O texto tamb√©m menciona algumas solu√ß√µes como '\n",
      "                       'reciclagem, energias renov√°veis e conscientiza√ß√£o, mas '\n",
      "                       'n√£o aprofunda como essas pr√°ticas podem ser '\n",
      "                       'implementadas de forma eficaz.\\n'\n",
      "                       ' *   Em termos de conhecimento de mundo, o texto '\n",
      "                       'demonstra uma consci√™ncia geral dos problemas '\n",
      "                       'ambientais, mas carece de uma an√°lise mais aprofundada '\n",
      "                       'das causas e consequ√™ncias desses problemas. Al√©m '\n",
      "                       'disso, n√£o h√° cita√ß√µes ou refer√™ncias que sustentem as '\n",
      "                       'afirma√ß√µes apresentadas.\\n'\n",
      "                       ' *   **Recomenda√ß√µes:**\\n'\n",
      "                       '    *   Apresentar exemplos concretos de problemas '\n",
      "                       'ambientais e suas consequ√™ncias (ex: dados sobre o '\n",
      "                       'aumento da temperatura m√©dia global, exemplos de '\n",
      "                       'desastres naturais relacionados √†s mudan√ßas '\n",
      "                       'clim√°ticas, estat√≠sticas sobre o desmatamento na '\n",
      "                       'Amaz√¥nia).\\n'\n",
      "                       '    *   Aprofundar a discuss√£o sobre as causas e '\n",
      "                       'consequ√™ncias do desmatamento, polui√ß√£o e emiss√µes de '\n",
      "                       'gases.\\n'\n",
      "                       '    *   Detalhar como as pr√°ticas sustent√°veis '\n",
      "                       '(reciclagem, energias renov√°veis, conscientiza√ß√£o) '\n",
      "                       'podem ser implementadas de forma eficaz, com exemplos '\n",
      "                       'pr√°ticos.\\n'\n",
      "                       '    *   Adicionar cita√ß√µes e refer√™ncias a estudos, '\n",
      "                       'autores ou organiza√ß√µes que tratam do tema da '\n",
      "                       'preserva√ß√£o ambiental para dar mais credibilidade e '\n",
      "                       'embasamento ao texto.\\n'\n",
      "                       '\\n'\n",
      "                       ' ## An√°lise Estrutural\\n'\n",
      "                       '\\n'\n",
      "                       ' *   **Status:** Bom\\n'\n",
      "                       ' *   **Descri√ß√£o:** A reda√ß√£o apresenta uma estrutura '\n",
      "                       'textual clara e concisa, abordando a import√¢ncia da '\n",
      "                       'preserva√ß√£o ambiental de forma coerente. A introdu√ß√£o '\n",
      "                       'contextualiza o tema e apresenta a problem√°tica das '\n",
      "                       'mudan√ßas clim√°ticas. O desenvolvimento aponta para a '\n",
      "                       'necessidade de a√ß√µes conjuntas entre governos, '\n",
      "                       'empresas e cidad√£os, mencionando pr√°ticas sustent√°veis '\n",
      "                       'como reciclagem e uso de energias renov√°veis. A '\n",
      "                       'conclus√£o refor√ßa a import√¢ncia do comprometimento de '\n",
      "                       'todos para reverter os danos ambientais e construir um '\n",
      "                       'futuro sustent√°vel.\\n'\n",
      "                       ' *   Em termos de gram√°tica e ortografia, o texto est√° '\n",
      "                       'correto. O vocabul√°rio √© adequado ao tema, e o estilo '\n",
      "                       '√© claro e objetivo. A coes√£o √© mantida atrav√©s do uso '\n",
      "                       'de conectivos que ligam as ideias de forma l√≥gica.\\n'\n",
      "                       ' *   **Recomenda√ß√µes:**\\n'\n",
      "                       '    *   Enriquecer a reda√ß√£o com exemplos concretos de '\n",
      "                       'a√ß√µes que governos, empresas e cidad√£os podem realizar '\n",
      "                       'para promover a sustentabilidade (ex: pol√≠ticas '\n",
      "                       'governamentais de incentivo a energias renov√°veis, '\n",
      "                       'iniciativas empresariais de redu√ß√£o de emiss√µes, a√ß√µes '\n",
      "                       'individuais de consumo consciente).\\n'\n",
      "                       '\\n'\n",
      "                       ' ## Recomenda√ß√µes Gerais\\n'\n",
      "                       '\\n'\n",
      "                       ' A reda√ß√£o possui uma boa estrutura e coes√£o, mas '\n",
      "                       'precisa de mais profundidade e embasamento te√≥rico '\n",
      "                       'para ser mais eficaz. Recomenda-se:\\n'\n",
      "                       '\\n'\n",
      "                       ' 1.  **Adicionar Exemplos Concretos:** Ilustrar os '\n",
      "                       'problemas ambientais e as solu√ß√µes propostas com '\n",
      "                       'exemplos reais e dados estat√≠sticos.\\n'\n",
      "                       ' 2.  **Aprofundar a An√°lise:** Explorar as causas e '\n",
      "                       'consequ√™ncias dos problemas ambientais de forma mais '\n",
      "                       'detalhada.\\n'\n",
      "                       ' 3.  **Detalhar as Solu√ß√µes:** Explicar como as '\n",
      "                       'pr√°ticas sustent√°veis podem ser implementadas de forma '\n",
      "                       'eficaz.\\n'\n",
      "                       ' 4.  **Incluir Refer√™ncias:** Citar estudos, autores e '\n",
      "                       'organiza√ß√µes relevantes para dar mais credibilidade ao '\n",
      "                       'texto.\\n'\n",
      "                       '\\n'\n",
      "                       ' Ao implementar essas melhorias, a reda√ß√£o se tornar√° '\n",
      "                       'mais informativa, persuasiva e impactante.\\n'\n",
      "                       ' ```'}\n"
     ]
    }
   ],
   "source": [
    "# Teste 1: Reda√ß√£o sobre meio ambiente\n",
    "essay1 = \"\"\"\n",
    "T√≠tulo: A Import√¢ncia da Preserva√ß√£o Ambiental\n",
    "\n",
    "A preserva√ß√£o do meio ambiente √© fundamental para garantir a qualidade de vida das gera√ß√µes futuras. \n",
    "O desmatamento desenfreado, a polui√ß√£o dos rios e oceanos, e as emiss√µes de gases poluentes t√™m causado \n",
    "mudan√ßas clim√°ticas significativas em todo o planeta.\n",
    "\n",
    "√â necess√°rio que governos, empresas e cidad√£os trabalhem juntos para implementar pr√°ticas sustent√°veis. \n",
    "A reciclagem, o uso de energias renov√°veis e a conscientiza√ß√£o ambiental s√£o passos essenciais nesse processo.\n",
    "\n",
    "Somente com a√ß√µes concretas e comprometimento de todos ser√° poss√≠vel reverter os danos causados ao meio ambiente \n",
    "e construir um futuro mais sustent√°vel para as pr√≥ximas gera√ß√µes.\n",
    "\"\"\"\n",
    "\n",
    "state = qualify_essay_without_session(essay_text=essay1)\n",
    "\n",
    "pprint(state)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "id": "a017c128",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'results_search': 'O relacionamento de Tata Estaniecki e J√∫lio Cocielo chegou '\n",
      "                   'ao fim ap√≥s 8 anos juntos. O an√∫ncio da separa√ß√£o foi '\n",
      "                   'feito por J√∫lio Cocielo em suas redes sociais no dia 16 de '\n",
      "                   'outubro de 2025.\\n'\n",
      "                   '\\n'\n",
      "                   'Tata Estaniecki e J√∫lio Cocielo estavam juntos desde 2017, '\n",
      "                   'e durante o relacionamento tiveram dois filhos, Beatriz, '\n",
      "                   'de 5 anos, e Caio, de 2 anos. O casal oficializou a uni√£o '\n",
      "                   'em mar√ßo de 2018 em Punta Cana, na Rep√∫blica Dominicana.\\n'\n",
      "                   '\\n'\n",
      "                   'Ap√≥s o an√∫ncio do t√©rmino, Tata Estaniecki retirou o '\n",
      "                   'sobrenome de J√∫lio de suas redes sociais. Apesar de n√£o '\n",
      "                   'ter se manifestado publicamente sobre o fim do casamento, '\n",
      "                   'ela aceitou a \"collab\" da publica√ß√£o de J√∫lio sobre o '\n",
      "                   't√©rmino em seu perfil, confirmando a veracidade da '\n",
      "                   'separa√ß√£o. Cocielo tamb√©m se afastou da internet.\\n'\n",
      "                   '\\n'\n",
      "                   'Em seu comunicado, J√∫lio Cocielo afirmou que a decis√£o foi '\n",
      "                   'tomada com respeito e di√°logo, e que a rela√ß√£o entre os '\n",
      "                   'dois seguir√° pautada pelo carinho e pela parceria na '\n",
      "                   'cria√ß√£o dos filhos. Ele tamb√©m pediu compreens√£o aos '\n",
      "                   'f√£s.\\n'}\n"
     ]
    }
   ],
   "source": [
    "query_text = \"Como est√° o relacionamento da Tata e o cocielo no momento?\"\n",
    "\n",
    "state = search_agent_without_session(query=query_text)\n",
    "pprint(state)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "c2f9b5d7",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "e440739b",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "id": "0765393d",
   "metadata": {},
   "source": [
    "# Teste Simples - Team Agents\n",
    "\n",
    "Notebook direto e enxuto para testar os agentes da pasta team via API:\n",
    "- **Lead Qualification Agent**: Valida, pontua e recomenda a√ß√µes para leads\n",
    "- **Search Agent**: Busca informa√ß√µes na web usando Google Search\n",
    "- **Essay Analyzer Agent**: Analisa reda√ß√µes (conte√∫do e estrutura) e gera relat√≥rio"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "313fe9b1",
   "metadata": {},
   "outputs": [],
   "source": [
    "import requests\n",
    "import json\n",
    "import uuid\n",
    "\n",
    "# Configura√ß√£o\n",
    "BASE_URL = \"http://localhost:8000\"\n",
    "\n",
    "# Nomes dos agentes dispon√≠veis\n",
    "AGENTS = {\n",
    "    \"lead\": \"lead_qualification_agent\",\n",
    "    \"search\": \"search_agent\", \n",
    "    \"essay\": \"essay_analyzer_agent\"\n",
    "}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "26bc0f26",
   "metadata": {},
   "outputs": [],
   "source": [
    "def run_agent(agent_name: str, input_data: str, user_id: str = \"u_test\") -> dict:\n",
    "    \"\"\"\n",
    "    Executa um agente e retorna o estado completo.\n",
    "    Cria e deleta a sess√£o automaticamente.\n",
    "    \"\"\"\n",
    "    session_id = f\"s_{uuid.uuid4().hex[:8]}\"\n",
    "    \n",
    "    # 1. Criar sess√£o\n",
    "    requests.post(\n",
    "        f\"{BASE_URL}/apps/{agent_name}/users/{user_id}/sessions/{session_id}\",\n",
    "        json={\"state\": {}, \"user_id\": user_id, \"session_id\": session_id}\n",
    "    )\n",
    "    \n",
    "    # 2. Executar agente\n",
    "    requests.post(\n",
    "        f\"{BASE_URL}/run\",\n",
    "        json={\n",
    "            \"appName\": agent_name,\n",
    "            \"userId\": user_id,\n",
    "            \"sessionId\": session_id,\n",
    "            \"newMessage\": {\"parts\": [{\"text\": input_data}], \"role\": \"user\"}\n",
    "        }\n",
    "    )\n",
    "    \n",
    "    # 3. Obter resultado\n",
    "    response = requests.get(\n",
    "        f\"{BASE_URL}/apps/{agent_name}/users/{user_id}/sessions/{session_id}\"\n",
    "    )\n",
    "    \n",
    "    # 4. Deletar sess√£o\n",
    "    requests.delete(\n",
    "        f\"{BASE_URL}/apps/{agent_name}/users/{user_id}/sessions/{session_id}\"\n",
    "    )\n",
    "    \n",
    "    return response.json().get(\"state\", {})\n",
    "\n",
    "\n",
    "def get_all_sessions(agent_name: str, user_id: str = \"u_test\") -> list:\n",
    "    \"\"\"Obt√©m todas as sess√µes de um usu√°rio para um agente espec√≠fico.\"\"\"\n",
    "    response = requests.get(\n",
    "        f\"{BASE_URL}/apps/{agent_name}/users/{user_id}/sessions\"\n",
    "    )\n",
    "    return response.json()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f334ccdb",
   "metadata": {},
   "source": [
    "---\n",
    "## üéØ Lead Qualification Agent\n",
    "\n",
    "Pipeline sequencial que valida, pontua e recomenda a√ß√µes para leads de vendas."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "0328918c",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "LEAD ALTA QUALIDADE\n",
      "Valida√ß√£o: v√°lido\n",
      "Score: 10: Tomador de decis√£o com or√ßamento aprovado, necessidade urgente e cronograma definido.\n",
      "A√ß√£o: Recomenda√ß√£o para a equipe de vendas:\n",
      "\n",
      "Agendar imediatamente uma demonstra√ß√£o personalizada para Carlos Silva, Diretor de TI da TechCorp Ltda. Dada a urg√™ncia, or√ßamento aprovado e cronograma definido, preparar uma proposta detalhada alinhada √†s necessidades espec√≠ficas da TechCorp e focada em um r√°pido retorno sobre o investimento. Priorizar este lead para fechamento imediato.\n",
      "\n"
     ]
    }
   ],
   "source": [
    "# Teste 1: Lead de alta qualidade\n",
    "lead1 = \"\"\"Nome: Carlos Silva\n",
    "Email: carlos.silva@techcorp.com.br\n",
    "Cargo: Diretor de TI\n",
    "Telefone: (11) 98765-4321\n",
    "Empresa: TechCorp Ltda\n",
    "Mensagem: Precisamos urgente de automa√ß√£o de vendas. Or√ßamento de R$ 50.000 aprovado. Implementa√ß√£o em 30 dias.\"\"\"\n",
    "\n",
    "state = run_agent(AGENTS[\"lead\"], lead1)\n",
    "\n",
    "print(\"LEAD ALTA QUALIDADE\")\n",
    "print(f\"Valida√ß√£o: {state.get('validation_status', 'N/A')}\")\n",
    "print(f\"Score: {state.get('lead_score', 'N/A')}\")\n",
    "print(f\"A√ß√£o: {state.get('action_recommendation', 'N/A')}\\n\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "e699c77f",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Sess√µes ativas para o usu√°rio u_test: []\n",
      "\n"
     ]
    }
   ],
   "source": [
    "# Verificar sess√µes ativas\n",
    "user_id = \"u_test\"\n",
    "all_sessions = get_all_sessions(AGENTS[\"lead\"], user_id)\n",
    "print(f\"Sess√µes ativas do Lead Agent para {user_id}: {len(all_sessions)} sess√£o(√µes)\\n\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "fcb1cf08",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "LEAD BAIXA QUALIDADE\n",
      "Valida√ß√£o: v√°lido\n",
      "Score: 2: Consulta geral sem detalhes de necessidade ou or√ßamento.\n",
      "A√ß√£o: Recomenda√ß√£o: Para Jo√£o, sugiro iniciar uma campanha de nutri√ß√£o, focando em conte√∫do educacional sobre nossos produtos e seus benef√≠cios. O objetivo √© fornecer mais informa√ß√µes e despertar o interesse em solu√ß√µes espec√≠ficas.\n",
      "\n"
     ]
    }
   ],
   "source": [
    "# Teste 2: Lead de baixa qualidade\n",
    "lead2 = \"\"\"Nome: Jo√£o\n",
    "Email: joao123@gmail.com\n",
    "Mensagem: Quero saber mais sobre seus produtos.\"\"\"\n",
    "\n",
    "state = run_agent(AGENTS[\"lead\"], lead2)\n",
    "\n",
    "print(\"LEAD BAIXA QUALIDADE\")\n",
    "print(f\"Valida√ß√£o: {state.get('validation_status', 'N/A')}\")\n",
    "print(f\"Score: {state.get('lead_score', 'N/A')}\")\n",
    "print(f\"A√ß√£o: {state.get('action_recommendation', 'N/A')}\\n\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "ed91b80d",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "LEAD INV√ÅLIDO\n",
      "Valida√ß√£o: v√°lido\n",
      "Score: 6: Necessidade expressa para um n√∫mero definido de usu√°rios.\n",
      "A√ß√£o: Recomenda√ß√£o: Dada a necessidade expressa do lead e o n√∫mero definido de usu√°rios, sugiro uma chamada de descoberta para entender completamente suas necessidades e avaliar como nosso CRM pode atend√™-las.\n",
      "\n"
     ]
    }
   ],
   "source": [
    "# Teste 3: Lead inv√°lido (sem contato)\n",
    "lead3 = \"\"\"Empresa: Empresa ABC\n",
    "Mensagem: Precisamos de CRM para 50 vendedores.\"\"\"\n",
    "\n",
    "state = run_agent(AGENTS[\"lead\"], lead3)\n",
    "\n",
    "print(\"LEAD INV√ÅLIDO\")\n",
    "print(f\"Valida√ß√£o: {state.get('validation_status', 'N/A')}\")\n",
    "print(f\"Score: {state.get('lead_score', 'N/A')}\")\n",
    "print(f\"A√ß√£o: {state.get('action_recommendation', 'N/A')}\\n\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "6499522d",
   "metadata": {},
   "source": [
    "### Teste em Lote - Leads"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "b02b8863",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "RESUMO - QUALIFICA√á√ÉO EM LOTE\n",
      "\n",
      "Lead         Valida√ß√£o            Score                                   \n",
      "------------------------------------------------------------------------\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 25%|‚ñà‚ñà‚ñå       | 1/4 [00:13<00:40, 13.61s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Alta         v√°lido               10: Tomador de decis√£o com or√ßamento a  \n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 50%|‚ñà‚ñà‚ñà‚ñà‚ñà     | 2/4 [00:26<00:26, 13.40s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Baixa        v√°lido               2: Consulta gen√©rica sem detalhes sobr  \n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 75%|‚ñà‚ñà‚ñà‚ñà‚ñà‚ñà‚ñà‚ñå  | 3/4 [00:39<00:12, 12.99s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Inv√°lido     v√°lido               6: Necessidade declarada para um taman  \n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|‚ñà‚ñà‚ñà‚ñà‚ñà‚ñà‚ñà‚ñà‚ñà‚ñà| 4/4 [00:52<00:00, 13.02s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Urgente      v√°lido               10: Tomador de decis√£o com or√ßamento a  \n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    }
   ],
   "source": [
    "from tqdm import tqdm\n",
    "\n",
    "leads = {\n",
    "    \"Alta\": lead1,\n",
    "    \"Baixa\": lead2,\n",
    "    \"Inv√°lido\": lead3\n",
    "}\n",
    "\n",
    "print(\"RESUMO - QUALIFICA√á√ÉO EM LOTE\\n\")\n",
    "print(f\"{'Lead':<12} {'Valida√ß√£o':<20} {'Score':<40}\")\n",
    "print(\"-\" * 72)\n",
    "\n",
    "for nome, lead in tqdm(leads.items()):\n",
    "    state = run_agent(AGENTS[\"lead\"], lead)\n",
    "    v = state.get('validation_status', 'N/A')[:18]\n",
    "    s = str(state.get('lead_score', 'N/A'))[:38]\n",
    "    print(f\"{nome:<12} {v:<20} {s:<40}\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "df5d5803",
   "metadata": {},
   "source": [
    "---\n",
    "## üîç Search Agent\n",
    "\n",
    "Agente de busca que utiliza Google Search para responder perguntas."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "4f406b04",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "CHAMADA DIRETA √Ä API\n",
      "Valida√ß√£o: v√°lido\n",
      "Score: 10: Diretor de TI com or√ßamento aprovado e necessidade urgente de implementa√ß√£o.\n"
     ]
    }
   ],
   "source": [
    "# Teste 1: Busca por informa√ß√µes atuais\n",
    "query1 = \"Quais s√£o as principais tend√™ncias de IA em 2025?\"\n",
    "\n",
    "state = run_agent(AGENTS[\"search\"], query1)\n",
    "\n",
    "print(\"BUSCA 1: Tend√™ncias de IA\")\n",
    "print(f\"Query: {query1}\")\n",
    "print(f\"Estado retornado: {json.dumps(state, indent=2, ensure_ascii=False)}\\n\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "b0aaae8a",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Sess√µes ativas para o usu√°rio u_direct: []\n",
      "\n"
     ]
    }
   ],
   "source": [
    "# Teste 2: Busca t√©cnica\n",
    "query2 = \"Como funciona o Google ADK para criar agentes?\"\n",
    "\n",
    "state = run_agent(AGENTS[\"search\"], query2)\n",
    "\n",
    "print(\"BUSCA 2: Google ADK\")\n",
    "print(f\"Query: {query2}\")\n",
    "print(f\"Estado retornado: {json.dumps(state, indent=2, ensure_ascii=False)}\\n\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "d15093eb",
   "metadata": {},
   "source": [
    "# Verificar sess√µes do Search Agent\n",
    "all_sessions = get_all_sessions(AGENTS[\"search\"], user_id)\n",
    "print(f\"Sess√µes ativas do Search Agent para {user_id}: {len(all_sessions)} sess√£o(√µes)\\n\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "4ea5bfd7",
   "metadata": {},
   "source": [
    "---\n",
    "## üìù Essay Analyzer Agent\n",
    "\n",
    "Pipeline paralelo + sequencial que analisa conte√∫do e estrutura de reda√ß√µes e gera relat√≥rio sint√©tico."
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "env",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.11"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
